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I. ABSTRACT___________________________________________________________ 
 This thesis focuses on the chemistry of 3H-1-benzazepine and synthetic routes for 
alkylation via a deprotonation/SN2 addition sequence. Previous thesis writers Laura 
Boulos and  Nathan Dvorkin laid the groundwork for this thesis. Currently, fully 
unsaturated 1-benzazepines are not common, and their reactivity is not well understood. 
This research could lead to the common use of 1-benzazepines as synthetic intermediates 
in the synthesis of important therapeutic agents. In addition, research by Takeda Industry 
dealing with a β-chemokine CCR5 receptor antagonist drug Tak-779 suggest that 1-
benzazepine derivatives exhibit increased effect for the treatment of HIV/AIDS. 
Although research on fully saturated 1-benzazepine synthesis has been minimal, over the 
past few years my mentor Dr. Keith Ramig has focused on mechanisms for synthesizing 
1-benzazepines. His previous students have shown that a 1-benzazepine can be 
deprotonated with lithium diisoproplyamide (LDA), and the resulting anion alkylated 
with alkyl halides. However, control of chemoselectivity and the replication of certain 
experiments were unsuccessful. Also, the yields in all cases were too low to be 
considered synthetically useful. These earlier experiments suggested that different bases, 
additives, and alkylating agents had to be tested to get the reaction to give high yields and 
selectivity. In the current work, three different electrophiles were examined using our 
new reaction methods, using KHMDS, a potassium-based strong base, and HMPA, a 
complexing agent. Alkylation attempts using methyl-, ethyl-, and benzyl- halides were 
tested with results indicating that methylation and ethylation leads to the formation of C3 
and N1 alkylated products while benzylation leads to the formation of N1 and C3, or N1 
and C5 products, depending on the deprotonating agent used. In most cases, the 
alkylation yields were excellent. The new synthesis method allows for the production of 
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N-methyl- and N-benzyl-1-benzazepines which were suitable for study by X-ray 
crystallography.  
II. INTRODUCTION_____________________________________________________ 
 HIV, human immunodeficiency virus, has become a global epidemic since its first 
recognition  in 1981.
[1] 
Viral infection can occur by contact with another individual's 
blood, semen, pre-seminal fluid, breast milk, vaginal fluids, and rectal mucous.
[1] 
Thirty 
years after its discovery, there are still an estimated 50,000 Americans infected with HIV 
per year with someone in the U.S infected every 9.5 minutes.
[1] 
Based on statistics 
collected by the United Nations Programme on HIV/AIDS (UNAIDS), in 2011, 34 
million people are living with HIV, 2.5 million people became new infected with HIV, 
and 1.7 million died from AIDS-related illnesses worldwide. 
[2] 
A graph published by 
UNAIDS, shown in figure 1 below, represents the global trend of people living with HIV 
from 1990-2011.
[2] 
These statistics indicate the gravity of the HIV disease as the global 
population living with the virus continues to increase. 
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 In order to understand the current treatments available and the relevance of 
benzazepines to HIV, the structure and infection process of HIV needs to be explained.  
HIV is an RNA retrovirus which belongs to the viral family Retroviridae.
[3] 
The HIV 
virus consists of a core holding the material for replication, a capsid to hold the core, and 
an envelope used for infection. The core is composed of the HIV genome and several 
enzymes including one called reverse transcriptase which allows the RNA strand of HIV 
to be coded into double-stranded DNA.
[3] 
The envelope surrounding the capsid contains 
two types of spike proteins: gp120 used for attachment to the CD4+ cells and gp41 
necessary for fusion of the viral and host cell membranes to allow for HIV entry.  
 After initial infection by HIV from another individual's bodily fluid, the viral 
replicative cycle begins in which HIV rapidly propagates within and destroys specific 
lymphocytes called CD4+ T cells.
[1] 
Lymphocytes, a specific group of white blood cells, 
play a role in cellular immunity by both recognizing and destroying virus-infected cells 
and also creating memory cells which grants us immunity if another similar viral 
infection is to occur.
[3]
 However, because HIV works through a retro-viral mechanism, 
HIV is able to  proliferate within our CD4+ T cells preventing the infection from being 
detected and in the long run destroying our body's line of defense against any other 
possible infections.
[3] 
Treatment for HIV involves the use of Highly Active Antiretroviral 
Therapy (HAART) drug cocktail mixtures due to the high mutation rates of HIV seen 
when monotherapy, single-drug therapy, is used.
[3]
 
 Current HIV drug research is focused on a specific prevention of HIV entry into T 
cells with focus on a beta chemokine receptor, the CCR5 co-receptor.
[4]
 It was found that 
the β-chemokine CCR5 co-receptor is needed to be present in order for the gp120 spike 
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proteins of HIV to successfully bind to the CD4+ receptor. Due to the presence of the 
CCR5-Δ32 gene deletion, it was discovered that 10% of the population in Europe was 
highly resistant to the HIV virus. This CCR5-coreceptor deletion led to a population of 
individuals who were either largely resistant to HIV, (homozygous individuals), and 
individuals who had slower HIV progression rates and elevated resistance, (heterozygous 
individuals). Furthermore, the frequency of this gene in Europe has suggested that the 
CCR5-Δ32 deletion has been around for about 127,500 years  indicating that this gene is 
selectively favored and causes no ill effects in individuals with the absence of this co-
receptor.
[4] 
The above results from CCR5-Δ32 mutation led the search forβ-chemokine 











Figure 2 - TAK-779
 
 In 1999, the Takeda Chemical Industries discovered a lead known as TAK-779 
(Figure 2) which demonstrated specific and potent CCR5 co-receptor antagonist 
effects.
[5]
 However TAK-779 showed poor oral absorption, bringing forth a cascade of 
research to be performed in the next decade involving derivatives of TAK-779. In 2005, 
TAK-779 derivatives with the general structure in Figure 3 demonstrated enhanced oral 
absorptive capabilities. In addition, enhanced binding affinity towards the CCR5 co-
receptor was seen when alkylation occurred on the N atom of the 1-benzazepine ring 
highlighted in red in Figure 3.
[6,7] 
Furthermore, a patent was granted to Takeda Chemical 
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 The structure above, specifically the substructure from Figure 3 that is highlighted 
in red, is the focal point of my research. In addition to its discovery as a substructure in 
drug research, the 1-benzazepine is a cousin of benzodiazepine substructures found in 
various antidepressants such as Diazepam (Figure 4). The chemistry and pharmacology 
of benzodiazepines has a long and rich history, while benzazepines are newer drugs 
whose full potential remains to be tapped. The difference between 1-benzazepine and 
benzodiazepine is simply the switch of a carbon atom for a nitrogen atom at the 4th 
position of the azepine ring. The similarities in structure may allow us to apply 
knowledge from the benzodiazepine species towards understanding 1-benzazepine 
alkylations, specifically how alkyl groups can be placed at various positions on the ring. 
  The importance of this 1-benzazepine structure is that it is found in various 
pharmaceutical agents including but not limited to β-chemokine CCR5 receptor 
antagonist drugs for targeted HIV-1 treatment. Although compounds with partially 
saturated azepine rings are present in various antiviral agents, the fully 
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saturatedbenzazepine structure has not been studied thoroughly. A survey of previous 
synthesis methods of benzazepines like 2 provided syntheses with either labor intensive 






























 The 1-benzazepine structure can have three possible isomers as shown in 1, 2, and 
3 above. The difference in the three isomers is the positioning of the double bond within 
the 7-membered azepine ring. This movement of the double-bond within the ring changes 
the positioning of the hydrogen (H) atom (shown in red) in the molecule. In 1, there is a 
single hydrogen atom attached to the nitrogen atom while in 2 and 3 this "extra" H atom 
is at C3 and C5, respectively. Hence, the designation 1H, 3H, 5H in the names. 
 Singh and Batra reported a successful synthesis method for both 1H-1-
benzazepines and 3H-1-benzazepines by SnCl2-mediated reduction of alkanoate nitro 
groups although their procedure required several reactions and showed limited 
generality.
[9] 
Their synthesis method is shown in the condensed Scheme 1 with focus on 
3H-1-benzazepine.  
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Reagents and conditions: i) AcCl, pyridine, CH2Cl2, room temp., 3 h ii)NO2CH2CO2Et, 
K2CO3, DMF, 3 h; iii) SnCl2•2H2O, MeOH or EtOH, N2, reflux, 2 h 
 Kharraz et al. approached benzazepine synthesis differently. They explored the 
possibility of oxidation of 1H-1-benzazepineinto its isomer 5H-1-benzazepine followed 
by acid- or base-catalyzed rearrangement into 3H-1-benzazepine as shown in Scheme 
2.
[10,11] 


























c) acid catalyzed rearrangement
d) base catalyzed rearrangement
 
 Both methods are impractical for preparing a wide range of derivatives because 
the yields are either too low or the generality of the reaction was limited or not 
demonstrated. 
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 Recently, my mentors Dr. Keith Ramig and Dr. Edyta Greer published two papers 
outlining two efficient synthesis methodsfor producing 3H-1-benzazepine (Schemes 3 
and 4) with its structure shown below in Scheme 3.
[12,13] 
In contrast to the labor intensive 
reaction methods provided in Schemes 1 and 2, the method of Scheme 3 forms 2,4-diaryl-
3H-1-benzazepine 6 in one step, from 2-fluoroaniline 4 and aryl methyl ketones 5, with 
moderate to high yields.
[12] 





























Reagents and conditions: i-a) pTsOH, o-xylene, reflux, 4 h. i-b) reflux, 16 h 
 Further studies by Ramig et al. showed that R
1 
position on the aryl vinyl ketone 8 
(aldol condensation of 5 from Scheme 3) can be substituted for other large functional 
groups such as alkyl and p-methyl or p-trifluoromethyl-substituted phenyl rings (Scheme 
4).
[13] 
In addition, attempts at using Scheme 4 to produce C5-substituted 3H-1-
benzazepine 6 had some success when R
1
  and R
2
= (CH2)4, and R
2
= CH3or H.  Even so, 
this reaction method had its own limitations in flexibility of substitutions on the 3H-1-
benzazepines. Replacement of the alpha hydrogen atom with an alkyl group on 8 failed to 
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 This limitation brought forth a need for an alternative synthesis route which was 
suggested by Streef, who published a paper on azepine alkylation. Streef demonstrated 
that strong-base deprotonation of an azepine followed by reaction with electrophiles such 
as methyl iodide or benzyl bromide yielded 3-substituted azepine products 12, with the 
intermediacy of anion 11, with 60-65% yield as shown in Scheme 5.
[14] 
In comparison to 
benzazepine, structurally azepine contains solely the 7-membered azepine ring on the 
right of 9 without the phenyl ring on the left. Application of this method to benzazepines, 
is the basis of an Honors Thesis written by former Baruch student Laura Boulos.
 [15] 
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Experimental work performed by Laura Boulos 



























13 14 15  
 
Boulos’ study used lithium diisoproplyamide (LDA), a relatively strong base, to 
deprotonate benzazepine 13. This gave anion 14, to which was added alkyl groups such 
as methyl and benzyl, givingC3-alkylated 3H-1-benzazepines 15 (Scheme 6).
[15] 
Here is 
the summary of some facts on selectivity and reaction condition requirements she found: 
1. Reaction of 13 with LDA is successful and 3-alkylatedproducts,arepresumably 
formed from a bimolecular nucleophilic substitution (SN2) reaction using small 
alkyl groups. 
2. Temperature plays an effect on the efficiency: An extremely low temperature (-65 
°C) is needed. 
3. An excess of base (LDA) and alkylating agent is needed 
4. Using a small group like methyl produced a maximum yield of ~30%.  
5. NMR analysis in combination with X-ray crystallography confirmed the structure 
of 3-methyl-1-benzazepine. 
6. The parent molecule 13, in solution, shows conformational change (ring-flipping) 
by variable temperature NMR analysis. This is absent in the C3-methylated 
derivative, indicating the azepine ring is locked in one conformation.  
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7. Reactions using a large alkyl group such as benzyl (via benzyl bromide) generated 
all three isomers (1-, 3-, and 5- benzylated) 
a. The results are unexplained at this point because it is strange that all three 
isomers are produced when a large alkylating group is used but when 
using an extremely small group, methyl, the 1- and 5- methylated isomers 
are not seen. We predicted that large group should give higher selectivity, 
not lower. 
b. Many subsequent attempts to replicate this reaction have failed. My thesis 
will show that the benzylated isomer yielded is either the 3- or 5- 
benzylated isomer, depending on the reaction conditions. 
 
 Research by Boulos showed successful addition of an electrophile onto the C3 
position of 2,4-diphenyl-3H-1-benzazepine to yield a stable, non-ring-flipping structure. 
However, in order to name these newly alkylated compounds precisely, a brief 
introduction into stereochemistry is necessary. The term chiral, comes from the Greek 
word cheir which means "hand".
[16]
 This property called chirality or "handedness" is what 
differentiates structures such as our left hand from our right hand. This "handedness" is 
used to characterize two structures with a mirror-image relationship, but which are non-
super imposable. The relevance to our studies is shown in Scheme 6 (previous page), 
where alkylations at C3 has conferred upon the molecule the property of chirality, 
indicated by the use of the stereochemical descriptors R (for Rectus, Latin for right) an S 
(for Sinister, Latin for left). This mirror-image relationship chirality gives rise to two 
structurally similar species called R and S enantiomers (Figure 5). 













3S 3R  
Figure 5: Central chirality designated by R and Sdescriptors (X = alkyl ) 
 This chirality is the most common type, known as "central chirality". 3H-1-
benzazepines also exhibit another more subtle form of chirality, "planar chirality." Planar 
chirality is generally reserved for compounds devoid of a chiral center.
[17] 
However, non-
super imposable mirror images (enantiomers) of this structure still exist through ring-
flipping of the non-planar azepine ring. Through a ring-flipping mechanism, a 1-
benzazepine structure devoid of the X group, as in benzazepine 13(Scheme 6), is 
converted into its enantiomer. However, the central chirality designations cannot be 
applied to this species as two atoms attached to the C3 atom are identical. Therefore, 
planar chirality is necessary to designate the handedness of the azepine ring in the two 
possible conformations. To assign planar chirality descriptors (pR and pS), the formalism 
of Eliel and Mander is used.
[17] 
The first step is to define the molecular plane (6-
membered benzene ring and atoms in red, 13 (Figure 6) followed by designation of the 
pilot atom which is the highest priority atom first out of plane (C2, attached to phenyl 
(Ph) group in blue) (Figure 6). Next, three atoms nearest the pilot atom going into the 
plane of the benzene ring are labeled a, b, and c. Lastly, when looking at the position of 
the atoms from C2 using an overhead view, clockwise positioning of atoms a to b to c is 
designated pR and counterclockwise is designated pS. 































Figure 6: Planar chirality designated by pS and pR descriptors 
 For the characterization of alkylated 1-benzazepines, both forms of chirality will 
be discussed. Figure 7 below shows a summary of the four possible structures and their 




























pS, 3S pR, 3S
pR, 3R pS, 3R
 
Figure 7: Four possible stereoisomers based on planar and central chirality 
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 Molecular chirality is important because it has an important effect on the 
biological action of drugs. This is demonstrated by the general lock-and-key hypothesis 
which states that the better the complementary fit of the drug to the receptor, the more 
potent the drug will be.
[18] 
The role chirality plays in drug activity in the body includes 
both potency and effect ofthe drug. A classic example is Ibuprofen, a commonly 
consumed analgesic and anti-inflammatory drug sold as Advil or Motrin (Figure 8). In 
our body, only the S enantiomer of Ibuprofen is active. In addition, if a racemic mixture 
(containing both R and S) of ibuprofen is taken, the rate of reaction in the body is slowed 













Figure 8: Biological activity of Ibuprofen enantiomers 
 In a more extreme case, biological activity of enantiomers could differ completely 
as in 2R,3S-(+)-dextro- and 2S,3R-(-)-levo-propoxyphene (Figure 9). The dextroform is 
used as an analgesic agent while the levo form is sold separately as an antitussive (anti-
cough) agent.
[18] 
Differences in biological activity influenced solely by the three-
dimensional positioning of the atoms demonstrates the importance of characterizing 
compounds by chiral descriptors whenever possible. 















S R S R
2R, 3S-(+)-dextro-propoxyphene




Figure 9: Biological activity of Propoxyphene enantiomers 
 Currently, fully unsaturated 1-benzazepines are not common, and their reactivity 
is not well understood. This research could lead to the common use of 1-benzazepines as 
synthetic intermediates in the synthesis of important therapeutic agents.  Furthermore, if 
we are able to successfully synthesize and isolate the possible stereoisomers of a 1-
benzazepine, biological effects of the different enantiomers can be determined by 
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Theoretical work performed byNathan Dvorkin 
 
 Through computational studies performed by Dr. Edyta Greer and Nathan 
Dvorkin using the B3LYP method and 6-31G(d) basis set, some interesting aspects of 
methylation were noticed for the experimental work performed by Laura Boulos.
[19]
 The 
choice of the B3LYP/6-31G(d) method was chosen based on comparison of the X-ray 
crystal structure of 3-methyl-2,4-diphenyl-3H-1-benzazepine (16) (Figure 10, mixture of 
enantiomers with pR3R isomer shown arbitrarily) with a model achieved through 
computational studies. By comparison, bond angles and distances in the X-ray crystal 
structure of 16,and in the structure rendered via B3LYP/6-31G(d) method computational 
method proved to be nearly identical.
[19]
 This justified the use of B3LYP/6-31G(d) 








Figure 10: X-ray structure of 16    16 
 Their work focused on explaining the underlying factors that govern the 
selectivity of the C3 position of 13 during alkylation and the factors involved in the ring-
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flipping phenomenon seen in the parent 3H-1benzazepine compound and other 























Figure 11: Other possible methylated 1-benzazepine derivatives 
 The Honors Thesis written by former Baruch student Nathan Dvorkin correlated 
facts provided in the summary below: 
Gas Phase Calculations 
1. Modeling of the ring-flip barriers for parent (13) and methylated derivatives: 
a. The modeling of the ring-flip barrier for parent 3H-1-benzazepine 13 
shows that the energy barrier is 9.2 kcal/mol.  
b. The ring-flip barrier for 6-methyl-1-benzazepine 19 is 10.7 kcal/mol 
which is 1.5kcal/mol greater than the parent compound 13. 
c. Modeling of the ring-flipping barrier in 1-methyl- (17), 5-methyl- (18), 
and 6-methyl (19) showed that the energy barrier for the ring-flipping 
phenomenon in 17 and 18 were approximately 1.5 kcal/mol greater than in 
19.  
d. Modeling of the 3-methyl derivative 16 showed that it does not undergo 
ring-flip, thereby producing a conformationally stable compound. 
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2. Modeling of LDA base deprotonation on the azepine ring followed by methyl 
iodide alkylation: 
a. The lithium atom from the base LDA prefers the N1 position of the anion 
(Figure 12) 
 
Figure 12: Deprotonated anion of parent benzazepine 13 
b. Methylation at the C3 atom of 13 produces the most stable product 
(thermodynamically favored, lowest energy product) 
c. Methylation at the C5 atom of 13 has the lowest activation energy barrier 
(kinetically favored, lowest energy intermediate) 
Solvent Phase Calculations 
1. The C3 position is kinetically favored over C5 position during alkylation by 0.7 
kcal/mol. 
2. The C5-alkylated position is thermodynamically more stable than the C3-
alkylated product by 0.3 kcal/mol. 
 Research by Dvorkin showed that the metal cation lithium used during 
deprotonation and also the alkylating agent (methyl halide) influences the selectivity of 
the alkylation reaction. However, the results above have many inconsistencies that need 
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to be solved before a complete analysis can be given. First, the lithium cation favors the 
nitrogen atom of the azepine ring but the 1-methylated compound 17 was never seen. 
Second, modeling of the ring-flip barriers has yet to explain the underlying interactions 
that dictatering-flipping. Third, there are inconsistencies between the results generated in 
gas- and solvent-phase calculations. Lastly, the selectivity of larger alkyl group additions 
needs to be explained. 
Introduction of reagents for the experimental alkylation of 3H-1-benzazepine 13 
 In this thesis, a new base, potassium bis(trimethylsilyl)amide (KHMDS), and a 
complexing agent, hexamethylphosphoramide (HMPA), were tested. Similar to LDA, 
KHMDS is an amide which is a strong deprotonating agent. However, the use of 
potassium as a counter-ion will be the focus of some of the experiments performed in this 
thesis. In general, when a deprotonation reaction occurs, a positively charged metal 
cation is present in the deprotonated form of reactant as in the deprotonated intermediate 
14 (Scheme 6). In the deprotonated state, the lone pair of the anion (negative charge) is 















Figure 13: Resonance of 3H-1-benzazepine anion 
 In general, this negative charge should be able to move along the azepine ring 
allowing for substantial amounts of negative charge on the N1, C3, and C5 position. 
However, during the LDA reactions using methyl iodide, only the 3-methyl-1-
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benzazepine 16 was formed. This led to the question of whether or not the lone pair is 
moving along the azepine ring. When the counter-ion is lithium, it is possible that the 
charge is localized at a single carbon atom rather than going into resonance around a ring. 
This is due to a chemical property called electronegativity. Electronegativity is a 
quantitative number assigned to each element based on its ability to attract electrons 
towards itself. Based on electronegativity differences between two atoms or functional 
groups, we can assign whether the bonding interaction between the two is covalent or 
ionic. In a covalent bond, the electronegativity difference is small which means that the 
electrons are shared equally. In an ionic bond, the electronegativity difference between 








 In general, an electronegativity difference greater than 1.7 classifies a bond as 
ionic and bonds between a metal and non-metal would be ionic. This is because metals 
are known to have low electronegativity values while nonmetals have much higher 
values. However, because lithium has an electronegativity value of ~1 and carbon has a 
value of ~2.5, their difference in electronegativity is only 1.5. This value makes a bond 
between these two species fall into the polar covalent bond range. In this situation, a 
lithium-to-carbon bond is a lot more covalent than a typical ionic bond. A complicating 
factor in our case is the presence of the THF solvent. This solvent is required for the 
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deprotonation reaction to occur, but, as it is a reasonably strong complexing agent for 
lithium ions and is present in a large excess, the C-Li bond formed may be much more 
ionic and therefore the negative charge would be spread around to other atoms in addition 
to C3. The covalent vs. ionic character of the C-Li bond may be an important factor in 
explaining the selectivity of alkylation, but at this point there is not enough data to form a 
theory. 













Figure 14: Structure of HMPA 
 To test whether the ionicity of the C-Li bond is important to the alkylation 
selectivity, a strong complexing agent such as hexamethylphosphoramide(HMPA) can be 
added (Figure 14). In general, complexing agents are known to interact with metal 
cations because they are comprised of polar functional groups with many free electron 
pairs. In HMPA, the oxygen atom has two lone pairs available for complexation, and the 
electron pairs on the nitrogen atoms make this oxygen atom very electron-rich. If a 
complexing agent like HMPA is added to a reactant during a deprotonation reaction, the 
complexing agent will be expected to pull the counter-ion farther away from the 
organolithium product (Figure 15).
[20]
 
















Figure 15: Effect of HMPA on deprotonated anionic species 14
 
 KHMDS, like LDA, is generally known to be a strong base. Unlike LDA, 
however, KHMDS has potassium as the counter-ion. Potassium is one period directly 
below lithium on the periodic table so it is larger and slightly less electronegative 
compared to lithium. Potassium would be expected to form more ionic bonds with an 
anion leading to more resonance in the deprotonated species 14.  
 
 
Figure 16: Structure of Potassium bis(trimethylsilyl)amide (KHMDS) 
  
 Studies performed by Carlier et al. on benzodiazepines suggests that KHMDS and 
HMPA will have positive effects for the 1-benzazepine species in our studies.
[21-23]
 In 
their studies, addition of HMPA to LDA or the use of KHMDS and HMPA showed 
improved alkylation yields and also shortened reaction times. Following their results, a 
ratio of 1 equivalent of reactant to 6 equivalents of HMPA and 2.4 equivalents of 
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KHMDS will be used. Deprotonation using LDA required ~1 hour for a good yield but 
studies by Carlier et al. suggests 10-minute deprotonation time is sufficient for complete 
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III. Results and Discussion_________________________________________________ 
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  3-methyl-1-benzazepine 1-methyl-1-benzazepine 
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min 23 mmol 
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min 5% 70% 
  
 The first electrophile tested is methyl iodide. The reaction design followed the 
results provided by Boulos
[15]
, but modifications were made to deprotonation and 
alkylation durations based on the work of Carlier.
[21,23] 
In addition, several 1 M aqueous 
HCl solution washes were performed after the general work-up scheme to remove the 
HMPA. In entry 2 of Table 2, KHMDS and HMPA were used and success was 
immediately demonstrated by NMR analysis. The spectrum shows a quartet at 4.95 
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ppm(C3-H) and a doublet at .92 ppm (CH2) which matches identically to the high-
resolution NMR spectrum given in Boulos' thesis,
[15]
 of the 3-methyl-1-benzazepine 16. 
In addition, a singlet near 6 ppm (C3-H) and a singlet at 2.92 ppm (CH2) were seen which 
was indicative of the N-methyl derivative17. Radial chromatography gave pure N-
methyl-1-benzazepine 17 [32-59-1] and a mixture of 3-methyl-1-benzazepine 16 with 
3H-1-benzazepine 13 [32-59-2]. A combined 75% yield of alkylated products was 
achieved, showing the necessity of the base KHMDS and complexing agent HMPA. 
Compared to the LDA reactions in Boulos' thesiswhich stated a 30% yield, this is a 
significant increase.
[15] 
Recrystallization of both fractions using hexane and several drops 
of EtOAc produced yellow crystals. X-ray analysis of crystals of 17 confirmed that the 
methyl group was attached to the benzazepine at N1 (Oak Ridge Thermal Ellipsoid Plot  
(ORTEP) diagram below). 
ORTEP Diagram of 17 
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 Entry 1 of Table 2 shows the results obtained without the complexing agent 
HMPA. The NMR spectrum of the crude mixture showed trace amounts of 3H-1-
benzazepine 13, however, peaks indicative of methylated isomers were not present in the 
sample. This reaction was performed twice more, and the outcome was the same. This 
result shows that HMPA is essential in alkylation reactions using KHMDS as base, and 
methyl iodide as alkylating agent. This was not the case for the other alkylating reagents 
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 The alkylation reactions using ethyl halides gave two of the possible three 
isomers, 20 and 21. The structure of 3-ethylated-1-benzazepine21 is not confirmed yet, as 
it cannot be positively distinguished from the 5-ethylated product by its NMR spectrum, 
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and X-ray-quality crystals haven't been obtained yet. However, based on an NOE study 
(term defined and discussed on page 37) which confirmed the structures of 3-benzyl and 
5-benzyl-1-benzazepine compounds discussed in the next section, the evidence strongly 
suggests that we are dealing with a 3-ethylated compound. In the 3-benzyl-1-benzazepine 
23 isomer, a triplet of doublets centered at 5 ppm is seen for the proton on C3 (Figure 
17). In the 5-benzyl isomer, the spectrum around 5 ppm shows a sharp triplet for the 
proton on C5. Similarly, in the NMR spectrum of the 3- or 5-ethylated product, a triplet 
of doublets is seen. This splitting pattern strongly suggests that it is due to a proton at the 
same position, C3. 
   
Figure 17: Comparison of the NMR spectra of 3- and 5-alkylated  
benzazepines 24, 23, 21 
 The first alkylation reaction using ethyl iodide used LDA as base, (Table 3, entry 
1)under the same reaction conditions determined optimal by Boulos.
[15]
 This reaction was 
expected to produce only 3-ethylated product since methylation yielded only the C3-
methylated isomer. However, crude NMR analysis showed the presence of both an N-
ethylated isomer and the 3-ethylated isomer. The N-ethylated-1-benzazepine 20 was 
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characterized by a sharp doublet at 6.05 ppm for the C3 proton, a quartet centered at 3.2 
ppm for the CH2 group, and a triplet at 0.9 ppm for the CH3 group. The 3-ethyl-1-
benzazepine 21 was characterized by the presence of a triplet of doublets centered at 4.8 
ppm for the C3 proton and a mix of triplets and quartets within the 0.74-1.5 ppm region 
for the CH2CH3 ethyl side chain. This reaction will also serve as a control for the next 
five ethylation trials performed. 
 The second ethylation reaction employed 5.7 mmol of complexing agent HMPA 
(Table 3, entry 2).  The ethyl halide used for this reaction is ethyl bromide instead of 
ethyl iodide. The addition of HMPA with LDA turned the solution to a dark green/brown 
rather than green as seen in LDA deprotonation. NMR analysis of the crude mixture 
indicated approximately a 7:3 ratio of ethylated benzazepines to starting benzazepine 13. 
The 69% yield approximated by NMR shows a 1 to 0.42 ratio of N-ethylated-1-
benzazepine 20 to 3-ethylated-1-benzazepine 21. 
 A third reaction was performed beginning comparisons of LDA to KHMDS 
deprotonation for ethylation reactions. For this trial, (Table 3, entry 3), ethyl iodide and 
KHMDS are used. After the addition of KHMDS, the solution appeared purple and 10 
minutes was allowed to elapse before adding ethyl iodide. After EtI addition, 30 minutes 
was allowed to pass.The NMR spectrum of the crude product showed a 5 to 4 ratio of 
ethylated benzazepine to 3H-1-benzazepine 13.Comparison of the N-ethyl-1-benzazepine 
20 peak at around 6 ppm to 3-ethyl-1-benzazepine 21 triplet of doublet centered at 4.75 
ppm shows a 1:4 ratio.These results suggests that employing KHMDS as the 
deprotonating agent will improve the reaction yields. 
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 A fourth reaction was performed similar to the previous trial with the addition of 
11.5 mmols of HMPA (Table 3, entry 4). NMR analysis of the crude product showed 
small traces (<1%) of 3H-1-benzazepine 13, suggesting reaction of almost all starting 
benzazepine to ethylated products 20 and 21. Peak integration for the products shows 
29%N-ethyl-1-benzazepine 20 and 70% 3-ethyl-1-benzazepine 21. In both entries2 and 4, 
the addition of HMPA to the deprotonation mixture resulted in an improvement in 
synthesis yields. Comparing entries 3 and 4 shows that with this improved yield comes 
lower selectivity. 
 The last reaction, (Table 3, entry 5), was performed to compare whether a halide 
change in the alkylating agent would show an effect on product yieldsor selectivity. Ethyl 
bromide was substituted for ethyl iodide with all other reaction conditions held the same 
as entry 4. NMR analysis of the crude product showed a larger peak for starting 
benzazepine 13compared to entry 4 which indicates a lower alkylation yield. NMR 
analysis determined that 85% of the starting benzazepine was reacted to form ethylated 
benzazepine 20 and 21. However, this reaction produced 55% N-ethyl isomer and 30% 3-
ethyl isomers. Compared to the previous trial, the NMR spectrum suggests that a change 
in halide used will influence the selectivity of alkylation. 
 The five ethylation reactions performed above shows that synthesis yields 
improve when the complexing agent HMPA is used with both LDA and KHMDS. 
Reactions using KHMDS show greater yields.Entries 4 and 5 shows an interesting 
finding ,a reverse in isomeryields suggesting a halide effect. Radial chromatography was 
performed after combining the above products to separate N-ethyl-1-benzazepine from 3-
ethyl-1-benzazepine followed by recrystallization from hexane. However, both N-ethyl 
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and 3-ethyl isomers failed to give crystals. The structure of the N-ethyl isomer can be 
confirmed by its unique NMR spectrum, but the structure of the 3-ethyl isomer remains 
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 The third electrophile attempted was benzyl bromide. This is one of the most 
interesting and vexing reactions studied because of the findings by Boulos.
[15]
 In her 
thesis, it was stated that all three benzylated isomers were produced from a single 
reaction using  LDA. However, several attempts at re-producingher reaction (Table 4, 
entry 1 shows one of the attempts) failed to produce all three isomers with the NMR 
spectrum showing only the 5-benzyl isomer 24. In addition, recrystallization attempts for 
the benzylated products in the past had failed to produce any crystals suitable for X-ray 
crystallographic analysis so conclusive identification of the isomers was impossible.  
 In the six reactions performed below, numerous attempts to recrystallize the 3- 
and the 5-benzyl-1-benzazepine species were attempted. However, crystals suited for X-
ray crystallography were never successfully achieved. Since X-ray crystallography was 
not possible, a NOE study (Figure 18) was performed by our collaborator Dr. Gopal 
Subramaniam of Queens College. Nuclear Overhauser effect, NOE, is an NMR technique 
used to define the spatial relationships of atoms within a molecule. It relies on as the 
transfer of nuclear spin polarization from one nuclear spin population to another via 
cross-relaxation. NOE is a coupling effect that occurs through interactions of atoms in a 
three-dimensional space. Unlike spin-spin coupling, which occurs through atoms 
connected by chemical bonds, NOE occurs through space between atoms that are in close 
proximity. This is a common phenomenon seen and used in NMR spectroscopy to 
determine stereochemistry of a compound.
[24]
 



























23 24  
Figure 18: NOE comparison for 3-benzyl- vs. 5-benzyl-1-benzazepine 
 When comparing the two benzylated isomers above, it is clear that the 5-benzyl-
1-benzazepine 24 on the right has its C6 proton closer to the 2 hydrogen atoms on the 5-
benzylated side chain. In their native 3-dimensional orientation, these hydrogen atoms 
would interact due to close proximity while in the 3-benzyl-1-benzazepine 23structure on 
the left the hydrogen atoms (highlighted in red) are too far apart to cause an NOE effect. 
By comparing whether or not this NOE is present, conclusive identification of which 
benzylated isomer is seen can be determined. Below is a NOESY trace pattern for an 
isomerically pure sample of undetermined regiochemistry, given to Dr. Subramaniam. He 
was able todetermine it is as being the 3-benzylated isomer. 




Figure 19: NOE Trace from the 5.0 ppm proton of the 3-benzylated isomer 
 NOE trace from the proton at 5.0 ppm is shown on the top graph.  For 
comparison, the1D proton spectrum is shown in the bottom trace. We can see the NOEs 
to the C2 or C4 phenyl ring ortho protons (2H intensity at 7.50 ppm) and also additional 
NOEs to other phenyl-ring protons. Since there are three phenyl rings in the molecule, 
there are other possible NOEs which are not identified specifically to a particular phenyl 
ring. We can also see NOE to the methylene proton of the benzyl group at 2.50 and 2.41 
ppm.  The most important observation is that the 5.0 ppm (C3-H) proton shows no NOE 
to the two downfield doublets of the BZP ring. This would suggest that this C3-H is not 
near the C6-H, and therefore the compound is the 3-benzylated isomer. 
 The NOE trace above shows that the species with a triplet at 5.0 ppm (C3-H) and 
a doublet at 2.5 ppm indicates a 3-benzylated-1-benzazepine 23 product. This is an 
effective identification method for us in this case because the other isomer, now known to 
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be 5-benzyl-1-benzazepine 24, has a similar triplet at 5.1 ppm but its doublet is present at 
3.5 ppm. From this study, it is safe to say when comparing the two isomers, a doublet at 
2.5 ppm indicates 3-benzylated isomer while a doublet at 3.5 ppm indicates a 5-
benzylated isomer. 
 The first reaction performed (Table 4, entry 1) used benzyl bromide and LDA. 
After the addition of LDA, an hour was allowed to elapse before adding benzyl bromide 
and after adding it, another hour was allowed for the alkylation.NMR analysis of the 
crude mixture shows the presence of 5-benzyl-1-benzazepine 24 as determined by an 
NOE study (see above). Radial chromatography gave a mixed fraction containing 5-
benzyl-1-benzazepine 24 and 3H-1-benzazepine 13, plus pure fraction containing N-
benzyl isomer 22. Identification of N-benzyl-1-benzazepine 22 was confirmed by a sharp 
singlet at 5.9ppm for the proton at C3 and a singlet at 4.5 ppm for the CH2 of the benzyl 
group. Identification of 5-benzyl-1-benzazepine 24 was determined by a triplet at 5.1 
ppm for the proton at C5 and a doublet centered at 3.5 ppm for the CH2 of the benzyl 
group.A 38% yield of 5-benzyl-1-benzazepine 24 was calculated and recrystallization 
was attempted using hexane and several drops of EtOAC. A large hedge hog-shaped 
crystal clump (Figure 20 shows a microscopic view) was obtained, however, X-ray 
analysis by Dr. David Szalda of our department showed that the crystals formed were 
unsuitable for X-ray crystallography. 
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Figure 20: 5-benzyl-1-benzazepine 24 crystal clump 
 The second reaction performed (Table 4, entry 2) used an additional 11.5 mmols 
of HMPA. This reaction used double the ratio of HMPA to LDA normally used to see if 
larger amounts of complexing agents used would lead to a greater yield.After workup 
with the additional 1 M aqueous HCl solution washes, NMR analysis showed a 51% yield 
with the presence of N-benzyl-1-benzazepine 22 (21%) and 3-benzyl-1-benzazepine 23 
(30%).Compared to entry 1 using LDA only (even when in excess), addition of HMPA 
showed an improved yield. However, only the two other isomers were seen with HMPA 
present, indicating a drastic change in selectivity. 
 The third reaction performed (Table 4, entry 3) is a second trial of entry 2 with 
shortened LDA deprotonation and benzylation time and also the normal ratio of HMPA 
(5.7 mmol). After the addition of LDA, 10 minutes was allowed to elapse (as in KHMDS 
deprotonation) before adding benzyl bromide and after adding it, 30 minutes was allowed 
to pass. After workup with the additional 1 M aqueous HCl solution washes, NMR 
analysis showed a 52% yield with the presence of N-benzyl-1-benzazepine 22 (24%) and 
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3-benzyl-1-benzazepine 23 (28%). Results from this trial shows that addition of more 
than ~6 equivalents of HMPA and alkylation durations >30 minutes showed no increase 
in yield when HMPA is used. 
 The fourth reaction performed (Table 4, entry 4) begins the trials examining the 
effect of KHMDS deprotonation followed by benzylation. After the addition of KHMDS, 
10 minutes was allowed to elapse before adding benzyl bromide and after adding it, 30 
minutes was allowed to pass. NMR analysis of crude product showed an 84% yield with 
the presence of N-benzyl-1-benzazepine 22 (27%) and 3-benzyl-1-benzazepine 23 (57%). 
Employing KHMDS without HMPA showed that synthesis yields improve compared to 
LDA only. When compared to LDA with HMPA, the KHMDS reaction shows a greater 
synthesis yieldand a greater amount of C3-benzylation 
 After purification by radial chromatography, recrystallization of 22 from 
ethylacetate/hexane produced crystals suitable for X-ray crystallography. (Figure 21).  
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Figure 21: N-benzyl-1-benzazepine 22 crystals 
 X-ray analysis of crystals 22 confirmed that the benzyl group was attached to the 
benzazepine at N1 position (ORTEP Diagram below). 
ORTEP Diagram of N-benzyl-1-benzazepine 22 
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 The fifth and sixth reactions performed(Table 4, entries 5 and 6), examines the 
benzylation yields with the addition of HMPA along with KHMDS during the 
deprotonation process. Plus, the reaction solvent for entry 5 was 2:1 v:v Et2O:THF. Both 
reactions were allowed a deprotonation time of 10 minutes followed by a benzylation 
duration of 30 minutes. However, entry 5 used benzyl bromide while entry 6 used benzyl 
chloride. NMR analysis of the crude product of both reactions showed that the peak for 
starting 3H-1-benzazepine 13 was nowhere to be found. In addition, it was interesting to 
discover that the change of halide, in contrast to the ethylation reactions (Table 3), caused  
no significant shift in the isomer ratio. Within the limits of error for NMR analysis, the 
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IV. Experimental_________________________________________________________ 
Deprotonation and Alkylation of the 3H-1-benzazepine 13 




























Reagents and conditions: a) KHMDS or KHMDS + HMPA, THF, -65
o 
C,10 min 
deprotonation time b) CH3I, room temperature (r. t.), 30 min alkylation 
a) KHMDS [32-61] (Scheme 7) 
The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-dried 3-
neck reaction flask under N2 was added 3H-1-benzazepine 13 (295 mg, 1 mmol). This 
was followed by 10.0 mL anhydrous THF.  KHMDS (2.4 mL, 1.0M in THF, 2.4 mmol) 
was added to turn the color of the solution dark green. After 10 minutes CH3I (63 µL, 1 
mmol) was added in ratio to the total amount of 3H-1-benzazepine used. The slush bath 
was removed and there was no initial color change. After 30 minutes at room 
temperature, the solution turned into a dark orange solution. The dark orange solution 
was partitioned between 8-mL of H2O and 8-mL of Et2O in a separatory funnel. The 
aqueous layer H2O was extracted with two additional 8-mL Et2O portions. The organic 
layers were combined and washed with 3 x 8 mL of 1 M aqueous HCl solution to remove 
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HMPA. During transfer of the dark orange solution to the separatory funnel, a dark green 
semisolid was present at the base of the reaction flask but was dissolved later by an 
aliquot of the H2O used. The organic layers were combined and dried over CaCl2 and the 
solvent was removed under reduced pressure to give the crude product as a dark orange 
solution. Thin layer chromatography (TLC) analysis showed a mixture of unknown 
compounds. NMR spectroscopic analysis indicated there were no methylated 
benzazepine isomers in the solution. This reaction was performed twice with both 
experiments leading to the same conclusion. 
a) KHMDS + HMPA [32-57] (Scheme 7) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck reaction flask under N2 was added 3H-1-benzazepine 13 (590 mg,  2mmol). 
This was followed by 20.0 mLanhydrous THF and drop-wise addition of 
hexamethylphosphoramide (HMPA) (2 mL, 23 mmol). Potassium 
bis(trimethylsilyl)amide (KHMDS)(4.8mL, 1.0 M in THF, 4.8 mmol) was added to first 
turn the solution dark brown. After 10 minutes, CH3I (125 µL, 2 mmol) was added. The 
slush bath was removed and no initial color change was seen. After 30 minutes at room 
temperature, the solution turned dark purple, almost black. The solution was then 
partitioned between 15-mL of H2O and 15-mL of Et2O. The aqueous layer H2O was 
extracted with two additional 15-mLEt2Oportions. The organic layers were combined and 
washed with 3 x 15-mL of 1 M aqueous HCl solution to remove HMPA. The organic 
layer was then dried over CaCl2 and the solvent was removed under reduced pressure to 
give the crude product as a yellow viscous oil. The product was purified by radial 
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chromatography (1 mm plate, 1% EtOAc/Hexane). Isolated were 40mg of 17 (6% yield, 
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Reagents and conditions: a) LDA, KHMDS, or  KHMDS + HMPA,THF, -65
o 
C,10 min 
or 1 h deprotonation time b) EtX (Halide (X) = Iodide or Bromide), r. t., 30 min or 1 h 
alkylation 
a) LDA,1 h b) Ethyl Iodide (CH3CH2I), 1 h [32-80] (Scheme 8) 
 The reaction occurred at -65
o 
C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck reaction flask under N2 was added 3H-1-benzazepine 13 (295 mg, 1 mmol). 
This was followed by 10.0 ml anhydrous THF. Lithium diisopropylamide (LDA) (0.6 
mL, 2.0 M in THF/heptane/ethylbenzene, 1.2 mmol) was added to turn the solution 
brown.(1 mmol LDA was added after using enough LDA to first turn the content green, 
presumably showing creation of anion 14). After 1 hour, ethyl iodide (EtI) (96 µL, 1.2 
mmol) was added . The slush bath was removed and the solution remained green. After 1 
hour at room temperature, the solution had become yellow and was partitioned between8-
mL of H2O and 8 mL of Et2O. The aqueous layer was extracted with two additional 8-mL 
Et2O portions. The organic layers were combined and dried over CaCl2 and the solvent 
was removed under reduced pressure to give the crude product as a yellow viscous oil 
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weighing 291 mg. NMR spectroscopic analysis of the crude mixture showed 1:8 ratio of 
20 to 21, respectively, estimated to be a 42% yield (20 + 21). 
a) LDA + HMPA, 1 h b) Ethyl Bromide (CH3CH2Br), 30 min [34-49] (Scheme 8) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck reaction flask under N2 was added of 3H-1-benzazepine 13 (295mg, 1 
mmol). This was followed by 10.0 mL anhydrous THF with drop-wise addition of 
HMPA (1 mL, 11.5 mmols). LDA (0.6 mL, 2.0 M in THF/heptane/ethylbenzene, 1.2 
mmols) was added to turn the solution dark green. After 1 hour, ethyl bromide (75 µL, 1 
mmol) was added . The slush bath was removed and the solution remained a dark green 
color, followed later by a dark orange. After 30 minutes at room temperature, at which 
point it was appearing red brown, the solution was partitioned between 8-mL of H2O and 
8-mL of Et2O. The aqueous layer H2O was extracted with two additional 8-mL Et2O 
portions. The organic layers were combined and washed with 3 x 8-mL1 M aqueous HCl 
solution. The organic layer was then dried over CaCl2 and the solvent was removed under 
reduced pressure to give the crude product weighing 207 mg.NMR spectroscopic analysis 
of the crude shows a 7:3 ratio of ethylated benzazepines to 3H-1-benzazepine. Peak 
integration comparison of 20 to 21 shows a 5:2 ratio respectively.  
a) KHMDS, 10 min b) Ethyl Iodide, 30 min [32-66] (Scheme 8) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck reaction flask under N2 was added  3H-1-benzazepine 13 (295 mg, 1 mmol). 
This was followed by 10.0 mL anhydrous THF. KHMDS (2.4 mL, 1.0 M in THF, 2.4 
mmol)  was added to turn the yellow solution to purple. After 10 minutes, EtI (80 µL, 1 
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mmol) was added . The slush bath was removed and the solution remained purple. After 
30 minutes at room temperature, the solution appeared reddish/brown and was then 
partitioned between 8-mL of H2O and 8-mL of Et2O. The aqueous layer H2O was 
extracted with two additional 8-mL Et2O portions. The organic layers were combined and 
washed with  2 x 8-mL 1 MaqueousHClsolution. The organic layer was then dried over 
CaCl2 and the solvent was removed under reduced pressure to give the crude product as 
an orange viscouls oil weighing 278 mg. NMR spectroscopic analysis of the crude 
product shows a ratio of 4:5 3H-1-benzazepine to ethylated benzazepine, impurities were 
also seen but not included in this calculation. Peak integration comparison of 20 and 21 
shows a 1:4 ratio of ethylated products respectively. 
a) KHMDS + HMPA,10 min b)Ethyl Iodide, 30 min [32-75] (Scheme 8) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck reaction flask under N2 was added 3H-1-benzazepine 13 (295 mg, 1mmol). 
This was followed by 10.0 mL anhydrous THF and drop-wise addition of  HMPA (2 mL, 
11.5 mmol). KHMDS (2.4 mL, 1.0 M in THF, 2.4 mmols) was added to turn the solution  
brown. After 10 minutes, ethyl iodide (80 µL, 1 mmol) was added . The slush bath was 
removed and the solution instantly changed to an orange brown, followed by a 
reddish/champagne after 15 minutes. After 30 minutes at room temperature, the solution 
was partitioned between 8-mL of H2O and 8-mL of Et2O. The aqueous layer was 
extracted with two additional 8-mL Et2O portions. The organic layers were combined and 
washed with 3 x 8-mL1 Maqueous HCl solution. The organic layer was then dried over 
CaCl2 and the solvent was removed under reduced pressure to give 360 mg of crude 
product as a semisolid brown caramel. Thin layer chromatography (TLC) analysis using 
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5% EtOAc/hexane showed two prominent spots above the starting benzazepine 13 at Rf 
0.59 for N-ethyl isomer and Rf 0.39 for the 3-ethyl isomer. NMR spectroscopic analysis 
of the crude shows a 1:99 ratio of 3H-1-benzazepine to ethylated benzazepines. Peak 
integration comparison of 20 to 21 shows a 1:2.4 ratio respectively. Small amounts of 
impurities were seen in the mixture which were not used to calculate the ratio of 13 to 
ethylated compounds 20 and 21. The crude product was purified by radial 
chromatography on silica gel (2 mm plate, 2% EtOAc/hexane) to give two fractions. 
Isolated were 70 mg of 20 (21% yield, [32-76-1]) and 113 mg of 21 (35% yield, [32-76-
2]). 
a) KHMDS + HMPA, 10 min b) Ethyl Bromide, 30 min [32-72] (Scheme 8) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck reaction flask under N2 was added 3H-1-benzazepine 13 (295mg, 1 mmol). 
This was followed by 10.0 mL anhydrous THF with drop-wise addition of HMPA (1 mL, 
11.5 mmols). KHMDS (2.4 mL, 1.0 M in THF, 2.4 mmol) was added to turn the solution 
into a brown color. After 10 minutes, ethyl bromide (75 µL, 1 mmol) was added . The 
slush bath was removed and the solution remained a brown color,followed later by an 
orange. After 30 minutes at room temperature, the solution was then partitioned between 
8-mL of H2O and 8-mL of Et2O. The aqueous layer H2O was extracted with two 
additional 8 mL Et2O portions. The organic layers were combined and washed with 3 x 8-
mL1 Maqueous HCl solution. The organic layer was then dried over CaCl2 and the 
solvent was removed under reduced pressure to give the crude product weighing 308 
mg.NMR spectroscopic analysis of the crude shows a 1:5.7 ratio of 3H-1-benzazepine to 
ethylated benzazepines. Peak integration comparison of 20 to 21 shows a 1.8:1 ratio 
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respectively. Impurities were seen in the mixture which were not used to calculate the 
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Reagents and conditions: a) LDA, KHMDS, or  KHMDS + HMPA,THF, -65
o 
C,10 min 
or 1 h deprotonation time b) BnX (Halide (X) = Chloride or Bromide), r. t., 30 min or 1 h 
alkylation 
a) LDA, 1 h b) Benzyl Bromide (BnBr), 1 h [32-46] (Scheme 9) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck reaction flask under N2 was added 3H-1-benzazepine 13 (1.0g, 3.4 mmol). 
This was followed by 34.0 mL anhydrous THF. LDA (2.7 mL, 2.0 M in 
THF/heptane/ethylbenzene, 5.4 mmol), giving a dark green solution. After 1 hour, BnBr 
(642 µL, 5.4 mmol) was added in ratio to the total amount of LDA used. The slush bath 
was removed and no initial color change occurred. At 23
o
 C, the solution was a wine-red 
color. After 1 hour at room temperature, the solution waspartitioned between15-mL of 
H2O and 15-mL of Et2O. The aqueous layer was extracted with two additional 15-mL 
Et2O portions. The organic layers were combined and dried over CaCl2 and the solvent 
was removed under reduced pressure to give 1.99g crude product as a yellow viscous oil. 
The product was purified by radial chromatography on silica gel (4 mm plate, 2% 
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EtOAc/hexane). Isolated were 650 mg  of a mixture, [32-47-1] containing 488 mg (38% 
yield) of5-benzyl 24 and 163 mg of 3H-1-benzazepine 13, as judged by NMR analysis. 
a) LDA + HMPA, 1 h b) Benzyl Bromide (BnBr), 30 min [32-83] (Scheme 9) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck reaction flask under N2 was added 3H-1-benzazepine 13 (295 mg, 1 mmol). 
This was followed by 10.0 mL anhydrous THF and drop-wise addition of HMPA (1 mL, 
11.5 mmols). LDA ( 0.6 mL, 2.0 M in THF/heptane/ethylbenzene, 1.2 mmol) was added 
to turn the content green.After 1 hour, benzyl bromide (145 µL, 1.2 mmol) was added. 
Upon addition, instant color change to a red-orange was seen. After 5 minutes the 
solution turned yellow. After 30 minutes at room temperature, the solution was 
partitioned between 8-mL of H2O and 8-mL of Et2O. The aqueous layer was extracted 
with two additional 8-mL Et2O portions.  The organic layers were combined and washed 
with 3 x 8-mL1 Maqueous HCl solution. The organic layer was then dried over CaCl2 and 
the solvent was removed under reduced pressure to give the crude product as yellow 
viscous oil [32-83-1].NMR analysis of the crude mixture indicated a 1:1.4 ratio of 22:23. 
The product was purified by radial chromatography on silica gel (2 mm plate, 2% 
EtOAc/hexane) to give: 95 mg (25% yield) of N-benzyl-1-benzazepine 22 [32-81-1]) and 
95 mg (25 % yield) of 3-benzyl-1-benzazepine 23 [32-81-2]. 
a) LDA + HMPA, 10 min b) Benzyl Bromide (BnBr), 30 min [34-46] (Scheme 9) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck flask under N2 was added 3H-1-benzazepine 13 (298 mg, 1 mmol). This was 
followed by 10.0 mL anhydrous THF and drop-wise addition of HMPA (1 mL, 5.7 
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mmols). LDA (0.6 mL, 2.0 Min THF/heptane/ethylbenzene,1.2 mmol) was added, 
turning the solution dark red, almost brown. After 10 minutes, BnBr (145 µL, 1.2 mmols) 
was added and the slush bath was removed. The solution immediately turned to a red-
orange followed by a orange at 10
o
 C. After 30 minutes at room temperature, the solution 
settled at a yellow-orange. The solution was then partitioned between 8-mL of H2O and 
8-mL of Et2O. The aqueous layer was extracted with two additional 8-mL Et2O portions.  
The organic layers were combined and washed with 3 x 8-mL1 Maqueous HCl solution. 
The organic layer was then dried over CaCl2 and the solvent was removed under reduced 
pressure to give 343 mg yellow viscous liquid [34-46-1]. NMR analysis of the crude 
mixture indicated a 1:1.2 ratio of 22:23, equivalent to a 52% yield when the presence of 
starting material is taken into account The product was purified by radial chromatography 
(1 mm plate, 5% EtOAc/hexane) to give two fractions containing benzylated compounds. 
Isolated were 37 mg of N-benzyl-1-benzazepine 22 (with impurities, [34-47-1]) and 36 
mg of 3-benzyl-1-benzazepine 23 (65mg fraction with 29 mg of 13, [34-47-2]). 
a) KHMDS, 10 min b) Benzyl Bromide (BnBr), 30 min [32-54] (Scheme 9) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck flask under N2 was added 3H-1-benzazepine 13(590 mg, 2 mmol). This was 
followed by 20.0 mL anhydrous THF. KHMDS (4.8 mL, 1.0 M in THF, 4.8 mmol) was 
added turning the solution from dark green to purple. After 10 minutes,BnBr (240 µL, 2 
mmol) was added. Upon addition, the slush bath was removed with no initial color 
change. After 30 minutes at room temperature, the solution turned to a red-orange. The 
solution was partitioned between 15-mL of H2O and 15-mL of Et2O. The aqueous 
layerwas extracted with two additional 15 mL Et2O portions.The organic layers were 
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combined and dried over CaCl2 and the solvent was removed under reduced pressure to 
give crude product as an orange viscous oil [32-54-1]. NMR analysis of the crude 
mixture indicated a 1:2.1 ratio of 22:23. The product was purified by radial 
chromatography on silica gel (4 mm plate, 3% EtOAc/hexane) to give 3 fractions: [32-
56-1], [32-56-2], [32-56-3]. Isolated were 156 mg(20% yield) N-benzyl-1-benzazepine 
22and 357 mg(46% yield) 3-benzyl-1-benzazepine 23. 
a) KHMDS + HMPA, 10 min b) Benzyl Bromide (BnBr), 30 min [32-52] (Scheme 9) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck flask under N2 was added of 3H-1-benzazepine 13 (590 mg, 2mmols). This 
was followed by 20 mL anhydrous Et2O and 5.0 mL anhydrous THF, and drop-wise 
addition HMPA (4 mL, 23 mmols). KHMDS (4.8 mL, 1.0 M in THF, 4.8 mmols) was 
added to turn the solution from a light olive green to a deep green. After 10 minutes, 
benzyl bromide (240µL, 2 mmols) was added. Upon addition, the slush bath was 
removed and no intial color change was seen. After 30 minutes at room temperature, the 
solution deep red-brown. The solution was then partitioned between 15-mL of H2O and 
15-mL of Et2O. The aqueous layer was extracted with two additional 15-mL Et2O 
portions. The organic layers were combined and washed with 3 x 15-mL1 M aqueous 
HCl solution. The organic layer was dried over CaCl2 and the solvent was removed under 
reduced pressure to give the crude product as a brownish yellow caramel [32-52-1]. NMR 
analysis of the crude mixture indicated a 5:4 ratio of 22:23. The product was purified by 
radial chromatography on silica gel (2 mm plate, 3% EtOAc/hexane) to give 213 mg N-
benzyl-1-benzazepine 22 (28% yield, [32-55-1]) and 450 mg 3-benzyl-1-benzazepine 23 
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(59% yield, [32-55-2]). The inconsistencies of the isolated yields with the NMR yields 
calculated can be accounted for possibly due to an error in weighing. 
a) KHMDS + HMPA, 10 min b) Benzyl Chloride (BnCl), 30 min [32-85-1] (Scheme 9) 
 The reaction occurred at -65
o
 C using a dry ice/2-propanol slush bath. To a flame-
dried 3-neck flask under N2 was added 3H-1-benzazepine 13(295 mg, 1 mmol). This was 
followed by 10.0 mL anhydrous THF and drop-wise addition of HMPA (2 mL, 11.5 
mmol). KHMDS (4.8 mL, 1.0 Min THF, 4.8 mmol) was added dropwise, turning the 
solution brown. After 10 minutes, benzyl chloride ( 115µL, 1 mmol) was added. The 
slush bath was removed and an instant color change to orange was seen. The solution 
turned champagne red/orange after 5 minutes and after 30 minutes at room temperature, 
the solution was partitioned between 8-mL of H2O and 8-mL of Et2O. The aqueous layer 
was extracted with two additional 8-mL Et2O portions.  The organic layers were 
combined and washed with 3 x 8-mL 1 M aqueous HCl solution. The organic layer was 
combined and dried over CaCl2 and the solvent was removed under reduced pressure to 
give the crude product as a yellow viscous oil weighing 350 mg. NMR spectroscopic 
analysis shows the presence of N-benzyl-1-benzazepine 22 and 3-benzyl-1-benzazepine 
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V. Conclusion___________________________________________________________ 
 The studies performed in this thesis using the base KHMDS, complexing agent 
HMPA, and different halides lead to a new window of options for synthesizing 
alkylatedbenzazepines. Following the synthesis by Carlier et al. of alkylated 
benzodiazepines, the deprotonation and alkylation reactions of the 1-benzazepine 
moieties have improved significantly. In all three cases - for methylation, ethylation, and 
benzylation, -improvements in the yields were seenas well as some intriguing trends in 
isomer ratios. In alkylation reactions with KHMDS and HMPA, N-methyl-1-benzazepine 
17 and N-benzyl-1-benzazepine 22 were seen for the first time and characterized 
unequivocally by X-ray crystallography. 
 In terms of synthesis yields, comparison by NMR of crude product in each 
reaction shows significant improvements. In several cases, the compounds were purified 
by radial chromatography and the isolated yields were calculated. In previous work, the 
best alkylation yields using LDA was only 30%. It is shown here that use of 
KHMDS/HMPA gives yields of 85-100%. Even using KHMDS alone gives good yields. 
 In ethylation experiments, only the N-ethyl-1-benzazepine 20 and 3-ethyl-1-
benzazepine 21 isomers were seen in all cases. The use of KHMDS and HMPA led to 
higher yields. In the case of LDA compared to KHMDS/HMPA, the synthesis yield 
improved from 42% to 99%. In the benzylation reactions, although the three benzyl 
isomers  were never reproduced from a single reaction as was reported by Boulos,
[15]
 a 
new synthetic route using KHMDS/HMPA provided a means for producing N-benzyl- 22 
and 3-benzyl-1-benzazepine isomers 23.  
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 The trends in the dependence of isomer ratio on alkylating agent are not clear. For 
example, with LDA deprotonation followed by methylation, 3-methylated-1-benzazepine 
was seen while in an LDA deprotonation reaction followed by benzylation, 5-benzylated-
1-benzazepine was seen. The difference in isomer formation can imply that there are 
other factors that remain unidentified which affect the selectivity of the reactions 
performed. A methyl group  is much smaller than a benzyl group which could affect 
selectivity.   
 Solvent phase calculations performed by Dvorkin
[19]
 shows that the 3-methylated 
isomer  is the most thermodynamically stable followed by the 5-methylated  isomer. This 
can explain why the 3-methylated  product was seen during all methylation reactions 
performed if the product ratio is not kinetically controlled. However, in a benzylation 
reaction, because the functional group is very large, access to the C3 position can be 
hindered due to the presence of  two large phenyl groups on C2 and C4. Therefore steric 
interactions between the benzyl group and the two phenyl rings in the transition state can 
cause attack at the C5 position to be more kinetically favored. At this point, it is too early 
to explain with certainty the puzzling isomer ratios 
 During the reactions with the addition of HMPA to LDA or with KHMDS, 
significant increases in product yields were seen. This indicates strongly that HMPA 
increases the efficiency of deprotonation and/or increases the reactivity of the anion. 
Interestingly, unlike methylation and ethylation, benzylation reaction using KHMDS, 
KHMDS/HMPA, or LDA/HMPA lead to formation of N-benzyl- and 3-benzyl products 
while LDA reaction produces 5-benzyl-1-benzazepine. The ability to synthesize all three 
isomers would lead to more synthetic versatility if the regioselectivity can be brought 
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under control. This will require a complete understanding of the underlying mechanism 
of both the deprotonation and alkylation. 
 An effect of the halide on selectivity is seen in the case of ethylation. In the case 
of ethyl iodide compared to ethyl bromide using KHMDS and HMPA, there is significant 
change in isomer ratios for N- and 3-ethyl isomers. However, in the case of benzyl 
bromide compared to benzyl chloride using KHMDS and HMPA, the isomer ratios can 
be considered equal. However, the big halide effect in ethylation and the absence of 
halide effect in benzylation cannot be compared directly because different halides are 
compared in the two cases, plus on one case the solvent was mostly diethyl ether. 
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VI. Future work_________________________________________________________ 
 The improved synthesis yields and isomer productions through the synthesis route 
described in this thesis provides a start for much needed work. The reason for the 
differing selectivity seen in alkylation reactions needs to be modeled theoretically to 
obtain a deeper understanding. Gas-phase and solvent-phase calculations provided some 
insight into some factors influencing reactivity. However, modeling of the mechanisms of 
deprotonation using KHMDS and HMPA and modeling of ethyl and benzyl group 
additions should be studied. The ultimate goal will be to identify conditions that produce 
any isomer at will. 
 
 In addition, recrystallization of several compounds produced including N-ethyl-1-
benzazepine 20, 3-ethyl-1-benzazepine 21, 3-benzyl-1-benzazepine 23, and 5-benzyl-1-
benzazepine 24 has been unsuccessful in producing viable crystals for X-ray 
crystallography. More work is needed in this area. In addition, the halide atoms  seem to 
have an effect on isomeric selectivity seen in ethylation, but not in benzylation reactions. 
However, more halides need to be tested under carefully controlled conditions in order to 
develop a hypothesis. 
 
 Dr. David Szalda, our collaborator in the area of X-ray crystallography, noticed 
that some crystals of the parent 3H-1-benzaepine 13 formed a helical structure in several 
samples. Following this, hundreds of helical crystals were observed under a dissecting 
microscope (Figure 22). Crystal polymorphism is a generally known but poorly 
recognized phenomenon with the mechanism of twisting not established. We are at the 
beginning of  a collaboration with a crystal-polymorphism specialist, Professor Bart Kahr 
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of New York University, who is studying this kind of phenomenon.
[25,26] 
Since screw-like 
objects are chiral, we propose that this twisting phenomenon could be an indication of the 
enantiomeric configuration of our compound. If this is the case, then this left- or right-
handed twisting property may lead to a resolution of enantiomers. 
 
 
Figure 22. A right-handed helical crystal of 2,4-diphenylbenzazepine 13, at 40X 
magnification. 
 Lastly, another experiment we hope to perform is on the alkylation of 5H-1-
benazepine, the isomer of 3H-1-benzazepine 13. If the preparation of 5-methyl-1-
benzazepine24 and 5-ethyl-1-benzazepine is unsuccessful with any conditions tested with 
the LDA, KHMDS, and HMPA, alkylation using the 5H-1-benzazepine might provide us 
with a mechanism for synthesizing some unseen isomers and increasing the versatility in 
our general reaction scheme. The one flask-synthesis route for preparation of 3H-1-
benzazepine by Ramig et al. showed that the 3H-1-benzazepine product is produced 
along with 5H-1-benzazepine in a 12:1 ratio.
[13]
 During several sublimation attempts  -  
laboratory notebook # 32, page 97 - performed on pure 3H-1-benzazepine,melting the 
compound resulted in production of the equilibrium 12:1 ratio of 3H:5H. However, a 
suitable eluent for radial chromatography has not been found for reliable separation of the 
5H-1-benzazepine isomer. 
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IX. Appendix A: NMR Spectroscopy________________________________________ 
The data were recorded at 90 MHz using CDCl3 solvent referencing TMS. 
[32-46-1]
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X. Appendix B: NOESY for 3-benzyl-1-benzazepine___________________________
Downfield doublets at 7.70 and 7.54 belong to BZP ring. They can be confirmed by the 
fact that it integrates to 1 proton and shows cosy to triplet at 7.45, but the other one 
is inside the large peak. We are looking for an NOE to this doublet to confirm the 
proximity of the benzyl ring.
P a g e  | 96 
 
NOE trace from the 5.0 proton is shown on the top.  For comparison, 1d proton is 
shown in the bottom trace. We can see the NOEs to the phenyl ring ortho protons (2H 
intensity at 7.50 ppm) and also additional NOEs to phenyl ring protons. Since there are 3 
phenyl rings in the molecule, these are possible NOEs and they are not identified 
specificially to a particular phenyl ring. We can also see NOE to the methylene proton of 
the benzyl ring at 2.50 and 2.41 ppm.  Most important observation is that the 5.0 ppm 
proton shows no NOE to the two downfield doublets of the BZP ring. This would suggest 
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XI. Appendix C: Data Tables for X-Ray Crystallography______________________ 
 
 
Data Tables of the N-methyl-1-benzazepine 19 Crystal Structure 
Table 1.  Crystal data and structure refinement for KR0329. 
 
      Identification code                  kr0329  
 
      Empirical formula                    C23 H19 N  
 
      Formula weight                       309.39  
 
      Temperature                          296(2) K  
 
      Wavelength                           0.71073 A  
 
      Crystal system, space group        Orthorhombic,  Pbca 
 
      Unit cell dimensions              a = 17.2952(7) A   alpha = 90 deg.  
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    b = 9.6845(4) A    beta = 90 deg.  
    c = 21.2201(9) A   gamma = 90 deg.  
 
      Volume                                3554.3(3) A^3  
 
      Z, Calculated density                8,  1.156 Mg/m^3  
 
      Absorption coefficient               0.067 mm^-1  
 
F(000)                                1312  
 
      Crystal size                          .5 x .4 x .3 mm 
 
      Theta range for data collection      2.59 to 27.33 deg.  
 
      Limiting indices                   -21<=h<=22, -12<=k<=9, -
27<=l<=27  
 
      Reflections collected / unique       22368 / 4022 [R(int) = 0.0373]  
 
      Completeness to theta =     27.33     99.8 %  
 
      Absorption correction                None 
 
      Refinement method                  Full-matrix least-squares on F^2  
 
      Data / restraints / parameters       4022 / 0 / 218  
 
      Goodness-of-fit on F^2               1.033  
 
      Final R indices [I>2sigma(I)]        R1 = 0.0474, wR2 = 0.1150  
 
      R indices (all data)                 R1 = 0.0840, wR2 = 0.1384  
 
      Extinction coefficient               0.0031(6)  
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Table 2. Atomic coordinates ( x 10^4) and equivalent isotropic displacement parameters 
(A^2 x 10^3) for KR0329. U(eq) is defined as one third of the trace of the  orthogonalized 
Uij tensor.  
 
         
_______________________________________________________________________ 
 
          x                   y                 z           U(eq)  
         
_______________________________________________________________________ 
 
N(1)          142(1)       5964(1)       2198(1)       48(1)  
C(2)          139(1)       5966(2)       1528(1)       46(1)  
C(3)          614(1)       6796(2)       1206(1)       51(1)  
C(4)         1174(1)       7760(2)       1478(1)       47(1)  
C(5)         1559(1)       7492(2)       2013(1)       51(1)  
C(6)         1516(1)       6261(2)       2410(1)       50(1)  
C(7)          830(1)       5512(2)       2500(1)       48(1)  
C(16)        2168(1)       5863(2)       2747(1)       66(1)  
C(17)        2159(1)       4759(2)       3158(1)       76(1)  
C(18)        1482(1)       4032(2)       3241(1)       73(1)  
C(19)         824(1)       4395(2)       2912(1)       60(1)  
C(21)        -405(1)       5020(2)       1198(1)       50(1)  
C(22)        -482(1)       3649(2)       1380(1)       61(1)  
C(23)        -976(1)       2770(2)       1058(1)       69(1)  
C(24)       -1401(1)       3245(2)        559(1)       71(1)  
C(25)       -1340(1)       4601(2)        380(1)       77(1)  
C(26)        -849(1)       5482(2)        698(1)       65(1)  
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C(11)        -593(1)       5763(2)       2521(1)       58(1)  
C(41)        1319(1)       9062(2)       1122(1)       50(1)  
C(42)         728(1)       9685(2)        785(1)       66(1)  
C(43)         834(1)      10941(2)        486(1)       84(1)  
C(44)        1544(1)      11575(2)        508(1)       86(1)  
C(45)        2138(1)      10970(2)        828(1)       73(1)  
C(46)        2034(1)       9728(2)       1135(1)       60(1)  
         ________________________________________________________________  
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           Table 3.  Bond lengths [A] and angles [deg] for KR0329.  
           _____________________________________________________________  
 
N(1)-C(2)                     1.421(2)  
N(1)-C(7)                     1.4218(19)  
N(1)-C(11)                    1.457(2)  
C(2)-C(3)                     1.337(2)  
C(2)-C(21)                    1.488(2)  
C(3)-C(4)                     1.465(2)  
C(3)-H(3)                     0.9300  
C(4)-C(5)                     1.342(2)  
C(4)-C(41)                    1.492(2)  
C(5)-C(6)                     1.461(2)  
C(5)-H(5)                     0.9300  
C(6)-C(16)                    1.391(2)  
C(6)-C(7)                     1.403(2)  
C(7)-C(19)                    1.391(2)  
C(16)-C(17)                   1.381(3)  
C(16)-H(16)                   0.9300  
C(17)-C(18)                   1.377(3)  
C(17)-H(17)                   0.9300  
C(18)-C(19)                   1.381(3)  
C(18)-H(18)                   0.9300  
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C(19)-H(19)                   0.9300  
C(21)-C(26)                   1.385(2)  
C(21)-C(22)                   1.389(2)  
C(22)-C(23)                   1.386(2)  
C(22)-H(22)                   0.9300  
C(23)-C(24)                   1.369(3)  
C(23)-H(23)                   0.9300  
C(24)-C(25)                   1.371(3)  
C(24)-H(24)                   0.9300  
C(25)-C(26)                   1.380(3)  
C(25)-H(25)                   0.9300  
C(26)-H(26)                   0.9300  
C(11)-H(11A)                  0.9600  
C(11)-H(11B)                  0.9600  
C(11)-H(11C)                  0.9600  
C(41)-C(42)                   1.386(2)  
C(41)-C(46)                   1.394(2)  
C(42)-C(43)                   1.384(3)  
C(42)-H(42)                   0.9300  
C(43)-C(44)                   1.373(3)  
C(43)-H(43)                   0.9300  
C(44)-C(45)                   1.364(3)  
C(44)-H(44)                   0.9300  
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C(45)-C(46)                   1.380(3)  
C(45)-H(45)                   0.9300  
C(46)-H(46)                   0.9300  
C(2)-N(1)-C(7)              117.02(13)  
C(2)-N(1)-C(11)             117.91(13)  
C(7)-N(1)-C(11)             118.49(14)  
C(3)-C(2)-N(1)              120.70(14)  
C(3)-C(2)-C(21)             121.17(15)  
N(1)-C(2)-C(21)             118.13(13)  
C(2)-C(3)-C(4)              125.97(15)  
C(2)-C(3)-H(3)              117.0  
C(4)-C(3)-H(3)              117.0  
C(5)-C(4)-C(3)              122.63(15)  
C(5)-C(4)-C(41)             120.61(14)  
C(3)-C(4)-C(41)             116.73(14)  
C(4)-C(5)-C(6)              128.27(15)  
C(4)-C(5)-H(5)              115.9  
C(6)-C(5)-H(5)              115.9  
C(16)-C(6)-C(7)             118.24(16)  
C(16)-C(6)-C(5)             118.67(15)  
C(7)-C(6)-C(5)              122.95(14)  
C(19)-C(7)-C(6)             119.63(15)  
C(19)-C(7)-N(1)             121.09(15)  
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C(6)-C(7)-N(1)              119.15(14)  
C(17)-C(16)-C(6)            121.97(18)  
C(17)-C(16)-H(16)           119.0  
C(6)-C(16)-H(16)            119.0  
C(18)-C(17)-C(16)           119.18(18)  
C(18)-C(17)-H(17)           120.4  
C(16)-C(17)-H(17)           120.4  
C(17)-C(18)-C(19)           120.36(19)  
C(17)-C(18)-H(18)           119.8  
C(19)-C(18)-H(18)           119.8  
C(18)-C(19)-C(7)            120.62(18)  
C(18)-C(19)-H(19)           119.7  
C(7)-C(19)-H(19)            119.7  
C(26)-C(21)-C(22)           117.90(16)  
C(26)-C(21)-C(2)            120.80(15)  
C(22)-C(21)-C(2)            121.30(15)  
C(23)-C(22)-C(21)           120.69(17)  
C(23)-C(22)-H(22)           119.7  
C(21)-C(22)-H(22)           119.7  
C(24)-C(23)-C(22)           120.36(18)  
C(24)-C(23)-H(23)           119.8  
C(22)-C(23)-H(23)           119.8  
C(23)-C(24)-C(25)           119.67(18)  
P a g e  | 105 
 
C(23)-C(24)-H(24)           120.2  
C(25)-C(24)-H(24)           120.2  
C(24)-C(25)-C(26)           120.27(19)  
C(24)-C(25)-H(25)           119.9  
C(26)-C(25)-H(25)           119.9  
C(25)-C(26)-C(21)           121.10(18)  
C(25)-C(26)-H(26)           119.5  
C(21)-C(26)-H(26)           119.5  
N(1)-C(11)-H(11A)           109.5  
N(1)-C(11)-H(11B)           109.5  
H(11A)-C(11)-H(11B)         109.5  
N(1)-C(11)-H(11C)           109.5  
H(11A)-C(11)-H(11C)         109.5  
H(11B)-C(11)-H(11C)         109.5  
C(42)-C(41)-C(46)           117.56(16)  
C(42)-C(41)-C(4)            120.41(14)  
C(46)-C(41)-C(4)            121.98(16)  
C(43)-C(42)-C(41)           121.41(18)  
C(43)-C(42)-H(42)           119.3  
C(41)-C(42)-H(42)           119.3  
C(44)-C(43)-C(42)           119.8(2)  
C(44)-C(43)-H(43)           120.1  
C(42)-C(43)-H(43)           120.1  
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C(45)-C(44)-C(43)           119.9(2)  
C(45)-C(44)-H(44)           120.1  
C(43)-C(44)-H(44)           120.1  
C(44)-C(45)-C(46)           120.70(18)  
C(44)-C(45)-H(45)           119.6  
C(46)-C(45)-H(45)           119.6  
C(45)-C(46)-C(41)           120.66(18)  
C(45)-C(46)-H(46)           119.7  
C(41)-C(46)-H(46)           119.7  
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    Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for  KR0329. 
 The anisotropic displacement factor exponent takes the form:  
  -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]  
 
    
_______________________________________________________________________  
 
  U11       U22        U33        U23        U13        U12  
    
_______________________________________________________________________  
 
N(1)     42(1)      57(1)      46(1)       4(1)       0(1)      -4(1)  
C(2)     45(1)      47(1)      47(1)       0(1)      -2(1)      -1(1)  
C(3)     54(1)      55(1)      44(1)      -3(1)       1(1)      -7(1)  
C(4)     43(1)      52(1)      47(1)      -5(1)       8(1)      -4(1)  
C(5)     41(1)      52(1)      60(1)      -6(1)       3(1)      -3(1)  
C(6)     46(1)      51(1)      53(1)      -6(1)      -1(1)       6(1)  
C(7)     52(1)      46(1)      47(1)      -3(1)      -2(1)       4(1)  
C(16)    52(1)      69(1)      76(1)      -2(1)     -10(1)       9(1)  
C(17)    73(1)      73(1)      81(1)      -2(1)     -22(1)      24(1)  
C(18)    90(1)      56(1)      72(1)       6(1)     -14(1)      14(1)  
C(19)    72(1)      48(1)      61(1)       2(1)      -6(1)       0(1)  
C(21)    51(1)      49(1)      49(1)       0(1)      -1(1)      -5(1)  
C(22)    70(1)      50(1)      64(1)       1(1)     -12(1)      -4(1)  
C(23)    87(1)      49(1)      71(1)      -4(1)      -3(1)     -14(1)  
C(24)    78(1)      71(1)      63(1)     -12(1)      -7(1)     -21(1)  
C(25)    92(1)      74(1)      65(1)       3(1)     -28(1)     -14(1)  
C(26)    78(1)      57(1)      60(1)       6(1)     -17(1)     -12(1)  
C(11)    51(1)      62(1)      61(1)       7(1)       6(1)      -6(1)  
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C(41)    49(1)      55(1)      45(1)      -6(1)       6(1)      -8(1)  
C(42)    63(1)      75(1)      60(1)      10(1)      -7(1)     -18(1)  
C(43)    88(2)      86(2)      78(2)      24(1)     -17(1)     -13(1)  
C(44)   103(2)      75(1)      81(2)      21(1)     -15(1)     -27(1)  
C(45)    75(1)      71(1)      72(1)       2(1)       2(1)     -30(1)  
C(46)    55(1)      63(1)      62(1)      -2(1)       3(1)     -10(1)  
    
_______________________________________________________________________  
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         Table 5.  Hydrogen coordinates ( x 10^4) and isotropic displacement parameters 
(A^2 x 10^3) for KR0329.  
 
         ________________________________________________________________  
 
         x               y                z           U(eq)  
         ________________________________________________________________  
 
H(3)          586          6757           768          61  
H(5)         1897          8177          2149          61  
H(16)        2625          6356          2693          79  
H(17)        2603          4510          3377          91  
H(18)        1468          3292          3521          87  
H(19)         372          3888          2967          72  
H(22)        -199          3317          1720          73  
H(23)       -1018          1851          1181          83  
H(24)       -1730          2651           343          85  
H(25)       -1631          4929            43          92  
H(26)        -816          6401           574          78  
H(11A)       -982          6331          2328          87  
H(11B)       -539          6016          2956          87  
H(11C)       -743          4811          2492          87  
H(42)         250          9250           758          79  
H(43)         427         11353           270         101  
H(44)        1619         12416           306         104  
H(45)        2619         11399           840          87  
H(46)        2444          9330          1352          72   
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 Table 6.  Torsion angles [deg] for KR0329.  
         ________________________________________________________________  
 
C(7)-N(1)-C(2)-C(3)                                 -64.4(2)  
C(11)-N(1)-C(2)-C(3)                              144.38(16)  
C(7)-N(1)-C(2)-C(21)                              115.43(16)  
C(11)-N(1)-C(2)-C(21)                               -35.7(2)  
N(1)-C(2)-C(3)-C(4)                                   0.3(3)  
C(21)-C(2)-C(3)-C(4)                             -179.62(15)  
C(2)-C(3)-C(4)-C(5)                                  34.6(3)  
C(2)-C(3)-C(4)-C(41)                             -147.02(16)  
C(3)-C(4)-C(5)-C(6)                                   0.8(3)  
C(41)-C(4)-C(5)-C(6)                             -177.52(15)  
C(4)-C(5)-C(6)-C(16)                              149.64(17)  
C(4)-C(5)-C(6)-C(7)                                 -34.7(3)  
C(16)-C(6)-C(7)-C(19)                                -0.8(2)  
C(5)-C(6)-C(7)-C(19)                             -176.42(16)  
C(16)-C(6)-C(7)-N(1)                              175.23(15)  
C(5)-C(6)-C(7)-N(1)                                  -0.4(2)  
C(2)-N(1)-C(7)-C(19)                             -121.23(17)  
C(11)-N(1)-C(7)-C(19)                                29.8(2)  
C(2)-N(1)-C(7)-C(6)                                62.85(19)  
C(11)-N(1)-C(7)-C(6)                             -146.15(15)  
C(7)-C(6)-C(16)-C(17)                                 0.4(3)  
C(5)-C(6)-C(16)-C(17)                             176.26(18)  
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C(6)-C(16)-C(17)-C(18)                               -0.3(3)  
C(16)-C(17)-C(18)-C(19)                               0.6(3)  
C(17)-C(18)-C(19)-C(7)                               -1.0(3)  
C(6)-C(7)-C(19)-C(18)                                 1.1(3)  
N(1)-C(7)-C(19)-C(18)                            -174.84(16)  
C(3)-C(2)-C(21)-C(26)                               -46.0(2)  
N(1)-C(2)-C(21)-C(26)                             134.11(17)  
C(3)-C(2)-C(21)-C(22)                             133.84(18)  
N(1)-C(2)-C(21)-C(22)                               -46.0(2)  
C(26)-C(21)-C(22)-C(23)                               1.5(3)  
C(2)-C(21)-C(22)-C(23)                           -178.32(16)  
C(21)-C(22)-C(23)-C(24)                              -0.7(3)  
C(22)-C(23)-C(24)-C(25)                              -0.3(3)  
C(23)-C(24)-C(25)-C(26)                               0.4(3)  
C(24)-C(25)-C(26)-C(21)                               0.5(3)  
C(22)-C(21)-C(26)-C(25)                              -1.5(3)  
C(2)-C(21)-C(26)-C(25)                            178.39(18)  
C(5)-C(4)-C(41)-C(42)                            -148.00(17)  
C(3)-C(4)-C(41)-C(42)                                33.6(2)  
C(5)-C(4)-C(41)-C(46)                                29.2(2)  
C(3)-C(4)-C(41)-C(46)                            -149.20(16)  
C(46)-C(41)-C(42)-C(43)                              -1.8(3)  
C(4)-C(41)-C(42)-C(43)                            175.54(18)  
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C(41)-C(42)-C(43)-C(44)                               1.6(4)  
C(42)-C(43)-C(44)-C(45)                              -0.4(4)  
C(43)-C(44)-C(45)-C(46)                              -0.5(4)  
C(44)-C(45)-C(46)-C(41)                               0.3(3)  
C(42)-C(41)-C(46)-C(45)                               0.8(3)  
C(4)-C(41)-C(46)-C(45)                           -176.42(17)  
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Data Tables of the N-benzyl-1-benzazepine 24a Crystal Structure 
 
Table 1.  Crystal data and structure refinement for KR0404. 
 
      Identification code                  kr0404  
 
      Empirical formula                    C29 H28 N  
 
      Formula weight                       390.52  
 
      Temperature                          296(2) K  
 
      Wavelength                           0.71073 A  
 
      Crystal system, space group          Monoclinic,  C2/c  
 
      Unit cell dimensions              a = 20.4155(10) A   alpha = 90 deg.  
       b = 14.1585(7) A   beta = 100.548(2) 
deg. 
       c = 14.9648(6) A   gamma = 90 deg.  
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      Volume                                4252.5(3) A^3  
 
      Z, Calculated density                8,  1.220 Mg/m^3  
 
      Absorption coefficient               0.070 mm^-1  
 
F(000)                                1672  
 
      Crystal size                      0.50 x 0.27 x 0.20 mm 
 
      Theta range for data collection      2.77 to 27.53 deg.  
 
      Limiting indices                  -26<=h<=25, -18<=k<=18, -
19<=l<=19  
 
      Reflections collected / unique       27820 / 4894 [R(int) = 0.0276]  
 
      Completeness to theta = 27.53        99.8 %  
 
      Absorption correction             None 
 
      Refinement method                   Full-matrix least-squares on F^2  
 
      Data / restraints / parameters    4894 / 0 / 271  
 
      Goodness-of-fit on F^2               1.010  
 
      Final R indices [I>2sigma(I)]        R1 = 0.0429, wR2 = 0.0992  
 
      R indices (all data)                 R1 = 0.0692, wR2 = 0.1134  
 
      Largest diff. peak and hole          0.118 and -0.165 e.A^-3  
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Table 2.  Atomic coordinates ( x 10^4) and equivalent  isotropic displacement parameters 
(A^2 x 10^3) for KR0404.U(eq) is defined as one third of the trace of the orthogonalized 
Uij tensor.  
 
         
______________________________________________________________________  
 
  x              y                   z           U(eq)  
         
______________________________________________________________________  
 
N(1)         4989(1)       2720(1)        674(1)       51(1)  
C(2)         4495(1)       2261(1)         25(1)       45(1)  
C(3)         4351(1)       1357(1)        142(1)       46(1)  
C(4)         4657(1)        758(1)        897(1)       46(1)  
C(5)         5301(1)        827(1)       1294(1)       50(1)  
C(6)         5804(1)       1466(1)       1055(1)       49(1)  
C(7)         5653(1)       2384(1)        734(1)       49(1)  
C(16)        6467(1)       1176(1)       1173(1)       61(1)  
C(17)        6960(1)       1753(1)        967(1)       70(1)  
C(18)        6803(1)       2645(1)        643(1)       72(1)  
C(19)        6153(1)       2962(1)        526(1)       65(1)  
C(11)        4881(1)       3707(1)        891(1)       57(1)  
C(111)       4193(1)       3830(1)       1103(1)       53(1)  
C(112)       3982(1)       3287(1)       1760(1)       67(1)  
C(113)       3345(1)       3369(1)       1931(1)       86(1)  
C(114)       2902(1)       3986(2)       1438(1)       89(1)  
C(115)       3098(1)       4526(1)        780(1)       85(1)  
C(116)       3746(1)       4454(1)        619(1)       70(1)  
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C(21)        4152(1)       2824(1)       -758(1)       52(1)  
C(22)        3463(1)       2805(1)       -997(1)       64(1)  
C(23)        3139(1)       3356(1)      -1702(1)       90(1)  
C(24)        3494(1)       3934(1)      -2167(1)      105(1)  
C(25)        4176(1)       3960(1)      -1945(1)       94(1)  
C(26)        4509(1)       3405(1)      -1243(1)       70(1)  
C(41)        4217(1)         35(1)       1199(1)       47(1)  
C(42)        4441(1)       -867(1)       1457(1)       58(1)  
C(43)        4026(1)      -1513(1)       1764(1)       72(1)  
C(44)        3384(1)      -1278(1)       1815(1)       73(1)  
C(45)        3150(1)       -397(1)       1548(1)       73(1)  
C(46)        3561(1)        254(1)       1240(1)       60(1)  
         ________________________________________________________________  
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           Table 3.  Bond lengths [A] and angles [deg] for KR0404.  
           _____________________________________________________________  
 
N(1)-C(2)                     1.4227(15)  
N(1)-C(7)                     1.4245(16)  
N(1)-C(11)                    1.4596(16)  
C(2)-C(3)                     1.3320(17)  
C(2)-C(21)                    1.4828(17)  
C(3)-C(4)                     1.4597(16)  
C(3)-H(3)                     0.9300  
C(4)-C(5)                     1.3441(17)  
C(4)-C(41)                    1.4858(17)  
C(5)-C(6)                     1.4606(18)  
C(5)-H(5)                     0.9300  
C(6)-C(16)                    1.3942(18)  
C(6)-C(7)                     1.4002(18)  
C(7)-C(19)                    1.3872(18)  
C(16)-C(17)                   1.375(2)  
C(16)-H(16)                   0.9300  
C(17)-C(18)                   1.370(2)  
C(17)-H(17)                   0.9300  
C(18)-C(19)                   1.381(2)  
C(18)-H(18)                   0.9300  
C(19)-H(19)                   0.9300  
C(11)-C(111)                  1.505(2)  
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C(11)-H(1A)                   0.9700  
C(11)-H(1B)                   0.9700  
C(111)-C(116)                 1.3777(19)  
C(111)-C(112)                 1.378(2)  
C(112)-C(113)                 1.375(2)  
C(112)-H(12A)                 0.9300  
C(113)-C(114)                 1.372(3)  
C(113)-H(13A)                 0.9300  
C(114)-C(115)                 1.364(3)  
C(114)-H(14A)                 0.9300  
C(115)-C(116)                 1.390(2)  
C(115)-H(15A)                 0.9300  
C(116)-H(16A)                 0.9300  
C(21)-C(22)                   1.3863(19)  
C(21)-C(26)                   1.390(2)  
C(22)-C(23)                   1.381(2)  
C(22)-H(19)                  0.9300  
C(23)-C(24)                   1.365(3)  
C(23)-H(23A)                  0.9300  
C(24)-C(25)                   1.372(3)  
C(24)-H(24A)                  0.9300  
C(25)-C(26)                   1.385(2)  
C(25)-H(25A)                  0.9300  
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C(26)-H(26A)                  0.9300  
C(41)-C(46)                   1.3866(18)  
C(41)-C(42)                   1.3876(18)  
C(42)-C(43)                   1.381(2)  
C(42)-H(42A)                  0.9300  
C(43)-C(44)                   1.368(2)  
C(43)-H(43A)                  0.9300  
C(44)-C(45)                   1.368(2)  
C(44)-H(44A)                  0.9300  
C(45)-C(46)                   1.381(2)  
C(45)-H(45A)                  0.9300  
C(46)-H(46A)                  0.9300  
C(2)-N(1)-C(7)              116.03(10)  
C(2)-N(1)-C(11)             118.13(10)  
C(7)-N(1)-C(11)             119.13(10)  
C(3)-C(2)-N(1)              119.77(11)  
C(3)-C(2)-C(21)             122.41(11)  
N(1)-C(2)-C(21)             117.82(11)  
C(2)-C(3)-C(4)              125.86(11)  
C(2)-C(3)-H(3)              117.1  
C(4)-C(3)-H(3)              117.1  
C(5)-C(4)-C(3)              123.06(11)  
C(5)-C(4)-C(41)             120.91(11)  
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C(3)-C(4)-C(41)             116.01(10)  
C(4)-C(5)-C(6)              127.76(12)  
C(4)-C(5)-H(5)              116.1  
C(6)-C(5)-H(5)              116.1  
C(16)-C(6)-C(7)             117.66(12)  
C(16)-C(6)-C(5)             119.74(12)  
C(7)-C(6)-C(5)              122.57(11)  
C(19)-C(7)-C(6)             119.97(12)  
C(19)-C(7)-N(1)             121.31(12)  
C(6)-C(7)-N(1)              118.63(11)  
C(17)-C(16)-C(6)            122.04(14)  
C(17)-C(16)-H(16)           119.0  
C(6)-C(16)-H(16)            119.0  
C(18)-C(17)-C(16)           119.60(14)  
C(18)-C(17)-H(17)           120.2  
C(16)-C(17)-H(17)           120.2  
C(17)-C(18)-C(19)           120.05(14)  
C(17)-C(18)-H(18)           120.0  
C(19)-C(18)-H(18)           120.0  
C(18)-C(19)-C(7)            120.66(15)  
C(18)-C(19)-H(19)           119.7  
C(7)-C(19)-H(19)            119.7  
N(1)-C(11)-C(111)           110.04(10)  
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N(1)-C(11)-H(1A)            109.7  
C(111)-C(11)-H(1A)          109.7  
N(1)-C(11)-H(1B)            109.7  
C(111)-C(11)-H(1B)          109.7  
H(1A)-C(11)-H(1B)           108.2  
C(116)-C(111)-C(112)        117.96(15)  
C(116)-C(111)-C(11)         121.15(13)  
C(112)-C(111)-C(11)         120.82(13)  
C(113)-C(112)-C(111)        121.09(16)  
C(113)-C(112)-H(12A)        119.5  
C(111)-C(112)-H(12A)        119.5  
C(114)-C(113)-C(112)        120.43(18)  
C(114)-C(113)-H(13A)        119.8  
C(112)-C(113)-H(13A)        119.8  
C(115)-C(114)-C(113)        119.56(18)  
C(115)-C(114)-H(14A)        120.2  
C(113)-C(114)-H(14A)        120.2  
C(114)-C(115)-C(116)        119.91(17)  
C(114)-C(115)-H(15A)        120.0  
C(116)-C(115)-H(15A)        120.0  
C(111)-C(116)-C(115)        121.05(16)  
C(111)-C(116)-H(16A)        119.5  
C(115)-C(116)-H(16A)        119.5  
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C(22)-C(21)-C(26)           118.74(13)  
C(22)-C(21)-C(2)            120.20(12)  
C(26)-C(21)-C(2)            121.01(13)  
C(23)-C(22)-C(21)           120.55(17)  
C(23)-C(22)-H(19)          119.7  
C(21)-C(22)-H(19)          119.7  
C(24)-C(23)-C(22)           120.23(19)  
C(24)-C(23)-H(23A)          119.9  
C(22)-C(23)-H(23A)          119.9  
C(23)-C(24)-C(25)           120.14(17)  
C(23)-C(24)-H(24A)          119.9  
C(25)-C(24)-H(24A)          119.9  
C(24)-C(25)-C(26)           120.32(19)  
C(24)-C(25)-H(25A)          119.8  
C(26)-C(25)-H(25A)          119.8  
C(25)-C(26)-C(21)           120.01(18)  
C(25)-C(26)-H(26A)          120.0  
C(21)-C(26)-H(26A)          120.0  
C(46)-C(41)-C(42)           117.77(12)  
C(46)-C(41)-C(4)            120.11(12)  
C(42)-C(41)-C(4)            122.11(12)  
C(43)-C(42)-C(41)           120.68(14)  
C(43)-C(42)-H(42A)          119.7  
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C(41)-C(42)-H(42A)          119.7  
C(44)-C(43)-C(42)           120.64(15)  
C(44)-C(43)-H(43A)          119.7  
C(42)-C(43)-H(43A)          119.7  
C(43)-C(44)-C(45)           119.54(14)  
C(43)-C(44)-H(44A)          120.2  
C(45)-C(44)-H(44A)          120.2  
C(44)-C(45)-C(46)           120.25(15)  
C(44)-C(45)-H(45A)          119.9  
C(46)-C(45)-H(45A)          119.9  
C(45)-C(46)-C(41)           121.09(14)  
C(45)-C(46)-H(46A)          119.5  
C(41)-C(46)-H(46A)          119.5  
           _____________________________________________________________  
 
           Symmetry transformations used to generate equivalent atoms:  
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Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for  KR0404. 
The anisotropic displacement factor exponent takes the form:  
  -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]  
 
    
_______________________________________________________________________  
 
 U11        U22        U33        U23        U13        U12  
    
_______________________________________________________________________  
 
N(1)     49(1)      40(1)      61(1)      -4(1)       3(1)      -5(1)  
C(2)     46(1)      44(1)      46(1)      -1(1)       8(1)      -2(1)  
C(3)     47(1)      45(1)      45(1)      -2(1)       4(1)      -5(1)  
C(4)     51(1)      41(1)      45(1)      -1(1)       9(1)      -2(1)  
C(5)     54(1)      48(1)      47(1)       5(1)       7(1)       1(1)  
C(6)     47(1)      53(1)      45(1)      -2(1)       6(1)      -4(1)  
C(7)     46(1)      53(1)      48(1)      -3(1)       7(1)      -8(1)  
C(16)    52(1)      67(1)      63(1)      -3(1)       6(1)       4(1)  
C(17)    48(1)      89(1)      73(1)     -10(1)      13(1)      -1(1)  
C(18)    55(1)      89(1)      75(1)      -6(1)      19(1)     -21(1)  
C(19)    60(1)      62(1)      72(1)       3(1)      12(1)     -13(1)  
C(11)    65(1)      41(1)      63(1)      -3(1)       9(1)      -9(1)  
C(111)   68(1)      40(1)      51(1)      -8(1)       7(1)      -3(1)  
C(112)   77(1)      67(1)      59(1)       2(1)      12(1)      -3(1)  
C(113)   93(1)      92(1)      80(1)      -7(1)      35(1)     -12(1)  
C(114)   77(1)      95(1)      96(1)     -34(1)      22(1)       1(1)  
C(115)   92(1)      74(1)      84(1)     -20(1)       2(1)      30(1)  
C(116)   93(1)      49(1)      69(1)      -2(1)      17(1)      15(1)  
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C(21)    66(1)      42(1)      47(1)      -1(1)       7(1)       4(1)  
C(22)    69(1)      55(1)      62(1)      -3(1)      -3(1)       8(1)  
C(23)   100(1)      73(1)      82(1)      -3(1)     -22(1)      26(1)  
C(24)   161(2)      68(1)      71(1)      13(1)     -19(1)      27(1)  
C(25)   159(2)      61(1)      63(1)      16(1)      21(1)       0(1)  
C(26)    94(1)      58(1)      59(1)       8(1)      19(1)      -1(1)  
C(41)    52(1)      45(1)      44(1)       0(1)       8(1)      -5(1)  
C(42)    63(1)      48(1)      64(1)       5(1)      13(1)      -1(1)  
C(43)    86(1)      50(1)      78(1)      13(1)      12(1)      -7(1)  
C(44)    77(1)      69(1)      75(1)      11(1)      17(1)     -26(1)  
C(45)    59(1)      77(1)      85(1)       5(1)      21(1)     -10(1)  
C(46)    56(1)      54(1)      71(1)       5(1)      13(1)      -3(1)  
    
_______________________________________________________________________  
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         Table 5.  Hydrogen coordinates ( x 10^4) and isotropic  
displacement parameters (A^2 x 10^3) for KR0404.  
         
_____________________________________________________________________  
 
x             y             z           U(eq)  
         
_____________________________________________________________________  
 
H(3)         4026          1082          -299          55  
H(5)         5444           419          1777          60  
H(16)        6579           573          1397          73  
H(17)        7398          1539          1048          84  
H(18)        7135          3038           502          87  
H(19)        6050          3568           306          78  
H(1A)        4931          4103           379          68  
H(1B)        5211          3899          1410          68  
H(12A)       4274          2859          2093          81  
H(13A)       3214          3005          2385         103  
H(14A)       2470          4035          1551         106  
H(15A)       2800          4942           439         102  
H(16A)       3879          4833           177          84  
H(19)       3218          2419          -679          77  
H(23A)       2677          3333         -1862         108  
H(24A)       3273          4311         -2636         126  
H(25A)       4416          4351         -2266         113  
H(26A)       4972          3423         -1097          84  
H(42A)       4876         -1039          1423          70  
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H(43A)       4185         -2113          1939          86  
H(44A)       3109         -1713          2029          88  
H(45A)       2712          -236          1573          88  
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_____________________________________________________________________ 
          Table 6.  Torsion angles [deg] for KR0404.  
         ________________________________________________________________  
 
C(7)-N(1)-C(2)-C(3)                                  66.01(15)  
C(11)-N(1)-C(2)-C(3)                               -142.88(13)  
C(7)-N(1)-C(2)-C(21)                               -114.60(13)  
C(11)-N(1)-C(2)-C(21)                                36.51(16)  
N(1)-C(2)-C(3)-C(4)                                   0.22(19)  
C(21)-C(2)-C(3)-C(4)                               -179.14(12)  
C(2)-C(3)-C(4)-C(5)                                 -35.4(2)  
C(2)-C(3)-C(4)-C(41)                                146.20(13)  
C(3)-C(4)-C(5)-C(6)                                  -1.1(2)  
C(41)-C(4)-C(5)-C(6)                                177.19(12)  
C(4)-C(5)-C(6)-C(16)                               -147.58(14)  
C(4)-C(5)-C(6)-C(7)                                  34.4(2)  
C(16)-C(6)-C(7)-C(19)                                 1.39(19)  
C(5)-C(6)-C(7)-C(19)                                179.43(12)  
C(16)-C(6)-C(7)-N(1)                               -175.36(11)  
C(5)-C(6)-C(7)-N(1)                                   2.68(18)  
C(2)-N(1)-C(7)-C(19)                                116.95(14)  
C(11)-N(1)-C(7)-C(19)                               -33.85(18)  
C(2)-N(1)-C(7)-C(6)                                 -66.35(15)  
C(11)-N(1)-C(7)-C(6)                                142.85(12)  
C(7)-C(6)-C(16)-C(17)                                -1.3(2)  
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C(5)-C(6)-C(16)-C(17)                              -179.38(13)  
C(6)-C(16)-C(17)-C(18)                                0.5(2)  
C(16)-C(17)-C(18)-C(19)                               0.1(2)  
C(17)-C(18)-C(19)-C(7)                                0.0(2)  
C(6)-C(7)-C(19)-C(18)                                -0.8(2)  
N(1)-C(7)-C(19)-C(18)                               175.87(13)  
C(2)-N(1)-C(11)-C(111)                               49.55(15)  
C(7)-N(1)-C(11)-C(111)                             -160.26(11)  
N(1)-C(11)-C(111)-C(116)                           -122.54(14)  
N(1)-C(11)-C(111)-C(112)                             54.37(17)  
C(116)-C(111)-C(112)-C(113)                          -0.3(2)  
C(11)-C(111)-C(112)-C(113)                         -177.33(14)  
C(111)-C(112)-C(113)-C(114)                           1.1(3)  
C(112)-C(113)-C(114)-C(115)                          -0.7(3)  
C(113)-C(114)-C(115)-C(116)                          -0.5(3)  
C(112)-C(111)-C(116)-C(115)                          -0.8(2)  
C(11)-C(111)-C(116)-C(115)                          176.17(13)  
C(114)-C(115)-C(116)-C(111)                           1.2(2)  
C(3)-C(2)-C(21)-C(22)                                47.64(18)  
N(1)-C(2)-C(21)-C(22)                              -131.73(13)  
C(3)-C(2)-C(21)-C(26)                              -134.96(14)  
N(1)-C(2)-C(21)-C(26)                                45.67(17)  
C(26)-C(21)-C(22)-C(23)                              -0.1(2)  
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C(2)-C(21)-C(22)-C(23)                              177.40(13)  
C(21)-C(22)-C(23)-C(24)                              -0.8(3)  
C(22)-C(23)-C(24)-C(25)                               1.0(3)  
C(23)-C(24)-C(25)-C(26)                              -0.5(3)  
C(24)-C(25)-C(26)-C(21)                              -0.3(3)  
C(22)-C(21)-C(26)-C(25)                               0.6(2)  
C(2)-C(21)-C(26)-C(25)                             -176.84(14)  
C(5)-C(4)-C(41)-C(46)                               141.57(13)  
C(3)-C(4)-C(41)-C(46)                               -39.99(17)  
C(5)-C(4)-C(41)-C(42)                               -37.63(18 
C(3)-C(4)-C(41)-C(42)                               140.81(13)  
C(46)-C(41)-C(42)-C(43)                              -1.5(2)  
C(4)-C(41)-C(42)-C(43)                              177.71(13)  
C(41)-C(42)-C(43)-C(44)                               0.4(2)  
C(42)-C(43)-C(44)-C(45)                               0.7(3)  
C(43)-C(44)-C(45)-C(46)                              -0.8(3)  
C(44)-C(45)-C(46)-C(41)                              -0.3(2)  
C(42)-C(41)-C(46)-C(45)                               1.4(2)  
C(4)-C(41)-C(46)-C(45)                             -177.80(13)  
         ________________________________________________________________  
 
         Symmetry transformations used to generate equivalent atoms:  
 
 
